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Abstract 
 
Human endogenous retroviruses (HERVs) are the result of ancient germ cell infections of 
human germ cells by exogenous retroviruses.  HERVs belong to the long terminal repeat (LTR) 
group of retrotransposons that comprise ~8% of the human genome. The majority of the HERVs 
documented have been truncated and/or incurred lethal mutations and no longer encode 
functional genes; however a very small number of HERVs seem to maintain functional in 
making new copies by retrotranspositon as suggested by the identification of a handful of 
polymorphic HERV insertions in human populations. The objectives of this study were to 
identify novel insertion of HERVs via analysis of personal genomic data and survey the 
polymorphism levels of new and known HERV insertions in the human genome. Specifically, 
this study involves the experimental validation of polymorphic HERV insertion candidates 
predicted by personal genome-based computation prediction and survey the polymorphism level 
within the human population based on a set of 30 diverse human DNA samples.  Based on 
computational analysis of a limited number of personal genome sequences, PCR genotyping 
aided in the identification of 15 dimorphic, 2 trimorphic and 5 fixed full-length HERV-K 
insertions not previously investigated.  These results suggest that the proliferation rate of 
HERVKs, perhaps also other ERVs, in the human genome may be much higher than we 
previously appreciated and the recently inserted HERVs exhibit a high level of instability.  
Throughout this study we have observed the frequent presence of additional forms of genotypes 
for these HERV insertions, and we propose for the first time the establishment of new genotype 
reporting nomenclature to reflect all possible combinations of the pre-integration site, solo-LTR 
and full-length HERV alleles.  
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Introduction 
 
Overview of transposable elements 
Transposable elements (TE) (often referred to as “jumping genes”) are sequences of 
DNA that are able to mediate their movement throughout the genome either via 
retrotransposition or by splicing itself and moving to a different location within the genome 
(Cordaux 2009).  Since Barbara McClintock first described TEs in 1953 while studying the 
mosaic colouration of maize, it has become well established that such elements are universal 
(McClintock 1953, Goodier 2008, Medstrand 2002).  Through the analysis of the many 
completed genome sequences, TEs are estimated to account for a major proportion of the plant 
and animal genomes, with approximately 50% for the human genome (Lander 2001). With such 
a high number of insertions and the ongoing activity for some of these members, they are 
thought to contribute significantly to the inter- and intra-species genetic variation. 
There are two major classes which TEs can be separated into based on their method of 
transposition within the genome: DNA transposons and retrotransposons (Cordaux 2009).  DNA 
transposons are able to move and insert themselves into new genomic sites in a “cut and paste” 
fashion while remaining as DNA (Stoye 2001).  DNA transposons were active during early 
primate evolution (~37 million years ago), but are currently thought to be immobile in the human 
genome (Griffiths 2001).  They are estimated to account for ~3 percent of the human genome 
(Cordaux 2009).  Conversely, retrotransposons duplicate through a “copy and paste” technique 
using RNA intermediates which are reverse transcribed before inserting into a new genomic 
location.  Retrotransposons are currently estimated to account for ~40 percent of the human 
genome (Cordaux 2009).  The class of retrotransposons is further divided into two sub-groups 
which are identified by the presence or absence of long terminal repeats (LTRs) (Bannert 2006).  
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Non-LTR retrotransposons represent the majority of TEs present in the human genome, 
collectively accounting for approximately one-third (Cordaux 2009).  The main elements 
composing the sub-group of non-LTR retrotransposons are: long interspersed element 1 (LINE-
1) and Alu. Each of these has been indisputably shown as currently active within humans; with 
more than 80 reported cases of de novo insertions causing genetic disorders.  The current 
estimated retrotransposition rates are as follows: Alu approximately one in twenty live births, 
LINE-1 approximately one in 200 live births (Konkel 2010), serving probably only as very rough 
guidelines. 
The LTR retrotransposons sub-category is composed of endogenous retroviruses (ERVs), 
which are estimated to account for approximately 8 percent of the human genome (Goodier 
2008).  Some of these elements have integrated exclusively within the human genome and thus 
also called human endogenous retroviruses (HERVs).  Many of the HERVs are thought to have 
inserted into the human genome roughly 25-30 million years ago (Cordaux 2009, Macfarlane 
2004).  Unlike other mammals such as mice, cats and sheep, there are currently no active 
infectious ERVs reported in humans (Bannert 2006).    Although their activity is currently 
thought to be very limited, the youngest elements HERV-K(HML-2) have shown evidence of 
persisting activity (Belshaw 2005, Turner 2001, Hughes 2004).  
Origin and classification of ERVS and HERVS 
Among RNA viruses, retroviruses are unique in their ability to integrate DNA copies of 
their genome into the genome of the infected cell (Johnson, Coffin 1999). Each retrovirus 
genome is composed of two copies of positive single-strand RNAs containing mainly four genes 
in the order 5’-gag-pro-pol-env-3’.  Gag encodes the matrix and capsid proteins, pro encodes the 
protease, pol encodes the reverse transcriptase and integrase, and env encodes the surface 
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envelope proteins (Figure 1) (Bannert 2006).  Very few exogenous viruses (such as HIV) possess 
additional non-structural accessory genes that facilitate their replication or impair host defences.  
It should be noted that these accessory genes are rare among endogenous viruses, with the 
exception of HERV-K (see ERV Classification below) (Kurth 2010).  After infection, a cellular 
tRNA molecule is used as a primer by the co-packaged reverse transcriptase in order to reverse 
transcribe the RNA into the ensuing double-stranded cDNA and virion protein (Sverdlov 2000, 
Bannert 2006). Next the integrase mediates the insertion of the DNA genome into the host 
chromosomal DNA at a seemingly randomized location, while generating a duplication of short 
sequence at the genomic integration site, flanking each LTR (Bannert 2006).  Generally these 
insertions occur in somatic cells, and passed onto all progeny cells (Bannert 2006).  If this 
integration takes place within a germ line cell, it will give rise to an endogenous retrovirus 
(ERV) in the genome of a new birth that is derived from the gamete carrying this allele 
(Macfarlane 2004).  When this occurs, the insertion is passed vertically from the infected host to 
their offspring  according to Mendelian laws (Bannert 2006).  It is important to note that there 
are no reports of the eradication of an ERV from an infected host (Johnson, Coffin 1999).  This 
has resulted in the chromosomes of mammals and most other vertebrates to be interlaced with 
ERV sequences, some considered ancient by the identical site of integration present in more than 
one species; whereas other have been acquired in more evolutionarily recent times as being 
specific to one species or even some individuals within the species (Tristem 2000). 
 
14 
 
 
Figure 1: Generalized organization of an integrated HERV (provirus).  
The viral sequence is flanked by a short duplication of host DNA produced during the integration 
process. The long terminal repeats (LTRs) at the 5΄ and 3΄ ends are composed of the A, B, and C 
regions. Transcription starts in the B region of the 5΄-LTR and the polyadenylation signal (pA) 
resides at the end of the B region in the 3΄-LTR. The primer binding site (PBS), commonly used 
to classify HERVs, is located in front of the gag reading frame. The gag portion encodes the 
structural portion of the viral matrix (MA), capsid (CA), and nucleocapsid (NU). It is processed 
by the product of the subsequent protease (pro). The reverse transcriptase (RT) and integrase 
(IN) are part of the polymerase (pol). The envelope protein (env) consists of the surface (SU) and 
transmembrane (TM) units and is translated from a spliced transcript. Complex retroviruses 
encode accessory proteins (e.g., Rec, Np9) at the pol/env junction. The location of a dUTPase 
encoded by several retroviruses, the position of the packaging signal (PS), and the polypurine 
tract (PPT) are also shown (* indicates another site of dUTPase in some retroviruses) [adapted 
from (Bannert 2006)]. 
 
	
	 ERV classification has become extremely complex as a result of different research teams 
providing arbitrary nomenclatures using a variety of classification criteria such as specificity of 
tRNA primer binding site, morphological type and copy numbers (Blomberg, Benachenhou et al. 
2009).  Many of these classifications are directly related to the small number of detected HERV 
sequences as well as the limited knowledge and methods used to study them at the time 
(Blomberg, Benachenhou et al. 2009).  This ambiguity has led to imprecise naming, as well as 
the subsequent overlapping of different family classifications as outlined by Blomberg et al. 
2009.  Current retrovirus taxonomy divides the status of a family into one of the seven genera: 
alpha-, beta-, gamma-, delta-, epsilon-, lenti- and spuma-retroviruses (Bannert 2006).  ERVs are 
currently loosely grouped into three classes due to their phylogenetic relatedness to exogenous 
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viruses (Bannert 2006).   Class I is composed of viruses that cluster with the gamma- and 
epsilon-genera, Class II ERVs are related to beta-retroviruses or very distantly to delta- and lenti-
viruses, while Class III is comprised of those most similar to spuma-viruses (Bannert 2006).  
Although many ERVs belong to Class II, it is important to note that there are none that are 
known to be closely related to lenti-viruses (e.g. HIV) (Bannert 2006).  Given that a traditional 
criteria used to name and classify a new human ERV was the sequence of 18 nucleotides 
constituting the primer binding site used to initiate reverse transcription, most HERVs are further 
organised by adding the one-letter code of the amino acid specificity of the most likely tRNA as 
a suffix to the acronym HERV (Bannert 2006).  Therefore a provirus using a lysine tRNA would 
be classified as HERV-K, whereas HERV-W would use tryptophan (Moyes 2007).  All of the 
Class II HERVs contain a lysine tRNA primer binding site, leading to the alternative 
nomenclature of simply HERV-K (Nelson, Carnegie et al. 2003).  Although mutational events 
have rendered most HERVs replication defective following integration, the HERV-Ks are 
thought to be the most active class of HERV, as they have retained the ability to encode a 
functional retroviral protein (Macfarlane 2004).  The HERV-K clade of beta retrovirus-like 
endogenous retroviruses currently contains a total of ten groups ranging from HML-1 to HML-
10 (Subramanian, Wildschutte et al. 2011).  They are most closely related to the mouse 
mammary tumor virus (MMTV), which is a causative agent for breast cancer in mice, leading to 
their acronym generated from human MMTV-like (Nelson, Carnegie et al. 2003).  Genome-wide 
studies have shown that the most recently active retroviruses belong to the HML-2 group, which 
has been estimated to include ~60 proviruses and over 2500 solo-LTRs in the human genome 
(Subramanian, Wildschutte et al. 2011).  The HML-2 group is further classified into type 1 or 
type 2 based on the presence or absence of a 292bp deletion at the pol-env junction respectively 
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(Subramanian, Wildschutte et al. 2011).  HML-2 elements are distinguished from their 
progenitor HERV-K(OLD) by their 96bp deletion in gag which has not disrupted the open 
reading frame, as well as a 8 to 23bp deletion found within their LTRs (Macfarlane 2004).  It is 
estimated that the HML-2 group integrated into the germ line roughly 28 million years ago, 
before the evolutionary divergence of lower Old World primates and hominoids (Macfarlane 
2004).  The HML-2 group is unique among all ERVs being the only group that includes human-
specific proviruses, of which 11 are known to be insertionally polymorphic within the human 
population (Barbulescu, Turner et al. 1999, Turner 2001, Costas 2001, Hughes 2004, Belshaw 
2005).  The insertion rate of the HML-2 group appears to have been fairly constant since the 
Homo-Pan divergence, lending to the evidence that replication competent HML-2 viruses may 
still exist within the human population (Subramanian, Wildschutte et al. 2011).  Although there 
has been no evidence of an infectious HERV in humans to date, other vertebrates have been 
found to contain replication-competent ERVs (Subramanian, Wildschutte et al. 2011).   
Polymorphism levels of HERVs in humans 
Upon integration, the ERV may retain the potential to be both vertically (parent to 
offspring) and horizontally (re-infection) transmitted.  Both the length of this stage and the 
proviral frequency reached in the host population are mainly determined by the effects that the 
integration has on the fitness of the host (Bannert 2006).  If the integration is neutral or in some 
way beneficial to the host, the allelic frequency is more likely to increase.  Conversely, the 
integration will not reach high allelic frequencies or remain in the host population for long if it 
causes strong detrimental or pathogenic effects (Bannert 2006).  For a detrimental proviral 
insertion to become fixed within a host population it must be preceded by either partial or 
complete inactivation of the insertion (Bannert 2006).  Unless selective pressure ensures the 
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retention of some functionality during evolution, the provirus will eventually be subjected to 
random modifications within the host genome resulting in the loss of expression and the capacity 
to proliferate (Bannert 2006).  These integrated proviruses then become fossilised in the host 
genome at which point further decay will eventually render the retroviral sequence barely 
recognizable.  It should be noted that the likelihood that two independent integrations will occur 
at the same chromosomal position is essentially negligible (Stoye 2001).  An increase in the 
provirus allele may also occur as a result of genetic drift, where a population bottle neck may 
rapidly alter the allelic frequencies by possibly sparing more individuals with a specific 
integration than those without (Bannert 2006).  This can also result from a founder effect, where 
a single individual or small group of provirus carriers create a population burst.  Eventually, an 
advantageous or neutral integration may become fixed within the genome of a species causing 
the loss of the insert-free allele (Bannert 2006). 
The activity of an ERV can be abolished through a variety of reversible and irreversible 
mechanisms.  The most drastic inactivation is caused by a homologous recombination between 
the two LTRs, resulting in the deletion of all viral sequences but a single chimeric LTR, termed a 
solo-LTR (Medstrand 2002, Vitte 2003).  Compared to their full-length ERV counterparts, it is 
estimated that solo-LTRs are approximately ten-fold more abundant within the human genome 
(Stoye 2001).  During host replication, mutations, deletions and recombination can also lead to 
the inactivation of their transcription regulatory elements and loss of protein function via non-
synonymous or non-sense mutations (Belshaw 2005).  Hypermethylation of ERV promoters can 
also quickly silence provirus expression (Moyes 2007).   
Currently there are only 11 HERVs that have been found to be insertionally polymorphic 
within the human population (Barbulescu, Turner et al. 1999, Turner 2001, Costas 2001, Hughes 
18 
 
2004, Belshaw 2005).  Barbulescu et al. (1999) were the first group to identify a polymorphic 
HERV.  In their study they were able to identify five loci where the full-length provirus and 
sLTR were found among the human samples but absent in the P.pygmaeus, G. gorilla, P. 
paniscus and P. troglodytes samples tested.  A study done by Costas (2001) found one 
polymorphic sLTR present among the human individuals tested.  In contrast Belshaw et al. 
(2005) were able to identify one polymorphic loci where both the sLTR and full-length provirus 
alleles were present in the individuals tested.  Arguably the most monumental finding with 
regards to HERV insertional polymorphism came from Turner et al. (2001) when they found two 
full-length proviruses to be polymorphic among a subset of human individuals they tested.  
These loci were named HERV-K113 and HERV-K115 and it was found that the provirus allele 
frequencies were 0.19 (9/48) and 0.4 (2/46) respectively, indicating that the insertion occurred 
fairly recently (Turner 2001).  They estimated these two HERVs integrated into the host genome 
within the last 1 million years (Turner 2001).  Interestingly, both HERV-K113 and HERV-K115 
were found to have full-length open reading frames (ORF) for all viral proteins.  The HERV-
K113 element appears to be capable of coding for all structural, regulatory and enzymatic 
proteins, as there are no detrimental mutations in the full-length provirus sequence (Turner 
2001).  HERV-K115 has obtained a 1bp deletion located 92bp upstream from the stop codon of 
the gag ORF, causing a frame shift that is likely to result in the inability to translate the pro and 
pol ORFs (Turner 2001).  Given this, it has been proposed that HERV-K113 represents the best 
candidate of a provirus that is still active today in humans (Turner 2001). 
Functional importance of HERVS in the genome 
With few exceptions, retrotransposon insertions are neutral or in some instance 
detrimental to the host, with the latter likely to be eliminated as a result of negative selection and 
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therefore unlikely to reach a high allele frequency within the population.  As HERVs litter our 
genome, their evolutionary conservation in the host genomes indicates that there must be some 
beneficial functions HERVs provide to the host.  It has been found that HERV-K (HML-2) LTRs 
contribute to the expression of nearby genes by acting as active promoters for host non-repetitive 
DNA transcription in vivo (Buzdin, Kovalskaya-Alexandrova et al. 2006).  Retrotransposon-
mediated sequence transduction and gene duplication have also been found to have led to both 
the creation of novel genes and aiding in the diversity of multi-gene families such as MHC- or T-
Cell receptor genes (Brandt, Schrauth et al. 2005, Xing, Wang et al. 2006, Agrawal, Eastman et 
al. 1998, Doxiadis, De Groot et al. 2008).  The reverse transcriptase has been shown to repair 
chromosomal breaks, and it has been suggested that telomerase is derived from the TE-coded 
reverse transcriptase (Teng, Kim et al. 1996, Eickbush 1997).  HERV LTRs have also been 
found to contain binding sites for the p53 regulator, accounting for over 30% of these binding 
sites genome wide (Wang, Zeng et al. 2007).  Consequently these HERV LTRs are suspected to 
contribute to the anti-oncogenic function of the stress-responsive p53 pleiotropic regulator 
(Wang, Zeng et al. 2007).  It has also been found in vitro that cellular resistance to infection by 
exogenous retroviruses can be conferred by the HERV-W envelope glycoproteins (Ponferrada, 
Mauck et al. 2003).  Another study found that HERV-Es are activated in some renal cancer cells, 
providing target antigens that were recognizable by cytotoxic T-cells after allogeneic 
hematopoetic stem cell transplantation (Takahashi, Harashima et al. 2008).  This resulted in the 
regression of the tumor, providing evidence that humans are apparently not immunologically 
tolerant of HERVs (Takahashi, Harashima et al. 2008).  The HERV-W and HERV-FRD 
envelope proteins (syncitin-1 and syncytin-2 respectively) have been detected in the placenta, 
and are thought to mediate the cell-cell fusion of cytotrophoblasts to syncytiotrophoblasts 
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resulting in the physiological morphogenesis of the placenta (Kurth 2010).  The previously 
demonstrated immunosuppressive property of retroviral ENV proteins has also been 
demonstrated from syncytin-2, which may be instrumental in fetal-maternal tolerance 
(Mangeney, Renard et al. 2007).  The immunosuppressive and fusogenic endogenous retrovirus 
proteins have also been detected in sheep and mice, leading to the evidence of positive selection 
over millions of years (Kurth 2010). 
Most, if not all HERV insertions that reach a high allelic frequency in the human 
population have acquired knockout mutations, deletions or undergone recombination events 
rendering them inactive (Bannert 2006).  Therefore it is not unexpected that the limited 
investigations have identified the majority of these insertions to be neutral or defective.  It is 
likely that any direct disease causing insertions may be too rare to allow the recognition of any 
infectious and replication competent (Bannert 2006).  A variety of studies have indicated that 
HERVK (HML-2) expression is up-regulated in tissues associated with a variety of diseases 
including melanomas, germ cell tumors, breast cancer, ovarian cancer, leukemias/lymphomas, 
schizophrenia and rheumatoid arthritis, although the functional consequences of this expression 
remain unknown  (Frank, Verbeke et al. 2008, Herbst, Sauter et al. 1998, Büscher, Hahn et al. 
2006, Hu, Hornung et al. 2006, Iwabuchi, Kakihara et al. 2004, Dickerson, Rubalcaba et al. 
2008, Sicat, Sutkowski et al. 2005, Subramanian, Wildschutte et al. 2011).  Despite research in 
these areas, there has been no clear data on which specific loci are being transcribed, nor the 
reasons for their activation (Subramanian, Wildschutte et al. 2011).  It has been proposed that the 
HERV immunosuppressive ENV proteins may indirectly facilitate tumor development through 
inhibition of an immune response, which may explain why high expression levels have been 
found in the diseases listed above (Nelson, Carnegie et al. 2003). 
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Methods for detection of HERV polymorphisms 
There have been a variety of approaches used for the detection of ERV diversity.  One of 
the earliest approaches was to stimulate ERV replication cells derived from one species and co-
cultivate them with appropriate indicator cells from a different species, which isolated replication 
competent endogenous viruses (Gifford, Tristem 2003).  Another approach used to approximate 
the distribution diversity of ERVs was through the use of low and high-stringency hybridization 
with retrovirus-derived probes (Gifford, Tristem 2003).  They have also been detected using 
synthetic primer binding site (PBS) probes (Gifford, Tristem 2003).  This technique uses the PBS 
probe hybridization to detect ERV-containing clones in genomic libraries based on bacterial or 
phage PI artificial chromosomes (BAC and PAC libraries respectively), followed by sequencing 
of the positive clones.  Although this method is very time-consuming, it is able to provide the 
complete sequence of an ERV insertion (Gifford, Tristem 2003).  A more efficient way of 
studying ERV diversity is to use primers flanking the insertion site, followed by PCR to amplify 
the novel ERVs from host genomic DNA (Gifford, Tristem 2003).  Although this method does 
not provide the complete sequence of the ERV insertion, it is a very useful tool for providing 
sufficient data for phylogenetic analysis among the samples tested.  PCR validation is now 
considered the gold standard for HERV polymorphism detection, as it allows the determination 
of the presence or absence of the insertion by comparing the sizes of the amplified products. 
Now with the availability of the complete genome sequences, computational methods are 
used to investigate this diversity by comparing different genomes.  These methods provide the 
opportunity to investigate the diversity of the ERV sequences as well as the distribution 
throughout the genome.  Computational algorithms such as RepeatMasker have allowed the 
automatic annotation of ERV insertions, providing a fast and extremely efficient basis for the 
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preliminary analysis of the structural variations found within the assembled genomes.  Although 
there are a variety of computational approaches for detecting structural variations, they are 
limited in detecting mobile element insertional polymorphisms, as they can only compare 
assembled genomes.  All of the recent genome projects (see below) have been generating 
genome sequences using next generation sequencing technologies, which result in a vast quantity 
of unassembled DNA sequence data, making this information useless to the algorithms requiring 
an assembled genome for comparison.  VariationHunter is the only tool that has been developed 
so far to identify mobile element  insertional polymorphisms by comparing the test genome and 
the human reference genome sequence using the unassembled next generation sequence data 
(Hormozdiari, Hajirasouliha et al. 2010). 
Evolution of sequencing technologies 
 Biological sciences have been fundamentally transformed by the ability to rapidly 
determine nucleic acid sequences (Korlach, Bjornson et al. 2010).  It has created a landslide of 
information that has revolutionised the way we think about scientific approaches, and stimulated 
an immense number of scientific advances. For over two decades the Sanger sequencing method 
(Sanger 1988) has been responsible for a variety of fundamental accomplishments, one of the 
most monumental being the completion of the first finished-grade human reference genome 
sequence (Lander 2001, Venter 2001, Collins, Lander et al. 2004).  What was once accomplished 
over years with a high financial burden using the Sanger method, can now be accomplished in 
weeks for magnitudes lower in price using the next generation sequencing (NGS) technologies 
(Bentley 2009).  
No matter which method is used, all NGS technologies follow the same three basic 
phases consisting of sample preparation, physical sequencing and re-assembly (Schadt 2010).  
23 
 
The genomic library is created by randomly fragmenting the template DNA into roughly 1kb 
long pieces.   The fragments are then spatially separated and immobilized to allow the parallel 
sequencing of thousands to billions of sequencing reactions (Metzker 2010).  The 4 main NGS 
technologies that currently dominate the commercial market are Roche/454, Illumina (Solexa), 
ABI (SOLid) and Ion Proton (Ion Torrent).  Roche/454 is generally the method of choice for 
applications where long read lengths are critical such as de novo sequencing and metagenomics. 
The Illumina/Solexa sequencing platform is best used for re-sequencing applications. 
The ABI SOLid sequencing platform is one of the most reliable technologies for identifying 
true single nucleotide polymorphisms (SNPs) (Shendure 2008).   The Ion Proton is best for 
smaller runs, and sequencing can occur in real time.  The read lengths and data outputs 
are summarized in  
Table 1.  The main bottlenecks that NGS face are found within the computational 
resources needed for assembly, annotation and analysis of sequence reads.  NGS technologies 
currently have read lengths far smaller than the smallest genomes (Miller 2010).  Shorter read 
lengths deliver less information per read, requiring higher coverage to satisfy minimum overlap 
criteria for assembly (Scholz, Lo et al. 2012).  Assembly software is challenged by genomic 
regions with shared perfect repeats, which can be indistinguishable when the repeats are longer 
than the read lengths (de Magalhães, Finch et al. 2010).  This challenge becomes amplified even 
further by the raw accuracy of these reads being inferior to Sanger sequencing (Scholz, Lo et al. 
2012).  In order to combat this issue, assembly software must tolerate imperfect sequence 
alignments to avoid overlooking library overlaps, which leads to false positives especially with 
polymorphic repeats (Miller 2010). 
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Table 1: Comparison of next generation sequencing technologies.  Adapted from (Scholz, 
Lo et al. 2012) 
Technology Average Read 
Length 
Output (Mb) Run Time 
Roche/454  400bp-700bp 500-900 10-20 hours 
Illumina/Solexa  35bp-150bp 400,000-600,000 8-14 hours 
ABI-SOLiD  35bp-60bp 71,000-155,000 8-12 hours 
Ion Proton 100-200bp 10-1000 3 hours 
 
 
Human genomes 
The advancement in sequencing technologies has allowed genome-wide association 
studies to identify genetic variants and provide insight into those that are associated with human 
disorders.   It has also allowed researchers to focus on the development and validation of 
prognostic and predictive markers to work towards the goal of personalized medicine (Ziogas 
2009).  The only finished-grade human reference genome sequence (NCBI build 36) was 
published in 2004 (Metzker 2010).  This genome is estimated to be composed of 99.99% 
European origin and still contains ~210 gaps (Snyder 2010).  With sequencing technologies 
creating fairly short read lengths, most genome sequencing projects rely on re-sequencing 
(assembly based on comparison to the reference genome) as opposed to de novo sequencing.  
Currently there are several thousand genome sequences that have been reported, providing 
valuable data for genome variant studies by comparing personal genomes to the reference 
genome (Snyder 2010).  The genome sequence of J. Craig Venter in 2007 compared to the 
reference genome identified 3.2 million single-nucleotide variants (SNVs) and 900,000 structural 
variants (SV).  The diploid genome of James D. Watson became the first whole genome to be 
sequenced using next generation sequencing technologies (Metzker 2010).  Comparison of the 
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James D. Watson genome with the reference identified 3.3 million SNVs (Wheeler, Srinivasan et 
al. 2008).  The 1000 Genomes Project (http://www.1000genomes.org/) began in January 2008, 
with the goal of sequencing the complete genomes of 1000 individuals from around the world 
using the NGS technologies.  This project aims to provide the genome data needed to discover 
and characterize the variants and polymorphisms with a frequency of at least 1% in the human 
genome by comparing each of the 5 major population groups that include: ancestry from Europe, 
East Asia, South Asia, West Africa and the Americas.  The project has completed the pilot phase 
which included a component known as the Trio Project, where whole-genome shotgun 
sequencing at a high coverage rate (averaging 42x) of two families (one Yoruba from Ibaden, 
Nigeria; one of European ancestry in Utah) that each included the two parents and one daughter 
(Altshuler, Lander et al. 2010).  The sequence read data generated using mainly the 
Illumina/Solexa and Roche/454 platforms.  All of these sequence reads have been made available 
to the scientific community through their website.  This is the data that the computational 
prediction of this study is based on.   
Objectives 
Using the personal genome sequence data generated from the next-generation sequencing 
platforms to study transposable element-derived structural variations represents an emerging and 
very promising direction for genetic and genomics research. Current data on polymorphic 
HERVs is extremely small. However, we believe that HERVs remain a certain level of 
transposition activity in the human genome and their level of polymorphism may be much higher 
than currently known. The main objectives of this study are to explore different approaches to 
discovering novel polymorphic HERV insertions aided by computational prediction from the 
analysis of available personal genome sequence data and to provide further characterization of 
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the newly identified HERV insertions in sequence and allele frequency.  These will allow us to 
assess the efficiency and accuracy of each approach, lending insight into the most efficient future 
discovery method and providing a more accurate assessment of the activity and polymorphism 
level of HERV insertions in the human genome, as well as their potential impact on genome 
function and evolution.   
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Materials and Methods 
The prediction methods chosen to be evaluated involve three distinct approaches.  Two of 
the methods involve computational prediction to assemble, align and compare the genomes of 6 
individuals to the human reference genome.  The third method involves screening the full-length 
HERV sequences identified within the human reference genome via PCR genotyping to examine 
if any insertional variation can be detected at that locus.  
Generation of TIPs_IN candidate list 
 The TIPs_IN list of candidate polymorphic HERV loci represent insertions that are 
present in the human reference genome but absent in one or more of the donor human genomes. 
This list was generated by Dr. Ping Liang via computational comparative genomics analysis, 
using the personal genome sequence data generated by the 1000 Genomes Project, based on the 6 
individuals from the two trio families, for which deep sequencing data were generated.  These 
families are from Yoruba in Ibaden, Nigeria and from European ancestry located in Utah, USA, 
with each consisting of the mother, father and a daughter.  Paired-end reads represent the two 
short reads of the two ends of a genomic fragment with a known estimated size (herein referred 
to as the library size).  The paired-end reads for the 6 individuals from the Utah and Nigerian 
families were used as the test genome data for predicting the TIPs_IN candidates using paired-
end mapping (PEM).  These paired-end reads were generated using the Illumina Solexa platform, 
with read lengths averaging 250bp at a standard deviation of 100bp.  Below is a brief description 
of the computational algorithms and procedures used. 
Alignment data of the pair reads for each genome was downloaded from the NCBI short 
read trace data web site at ftp://ftp.ncbi.nih.gov/1000genomes/ftp/data/. Paired-end reads 
showing a mapping distance (span size in the human reference genome) considerably larger than 
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the sequencing library size were selected for genotyping. Their location in the human reference 
genome was then compared to the locations of HERV sites that have already been annotated in 
that genome.  The presence of multiple pair reads with their two read mates located outside of a 
HERV insertion indicated a possible absence of the HERV insertion in the examined genome 
(Figure 2).  The predicted candidates were further processed for selection by requiring the 
absence of a recently duplicated region without the insertion in the human genome and the 
absence of the HERV insertion in the closely related chimpanzee genome. This was done based 
on the assumption that a polymorphic HERV insertion in human genome must have originated 
from a human-specific insertional event and as such should be absent in the genome of an 
outgroup species.  This final candidate list was subjected to experimental verification by PCR 
genotyping. 
 
 
Figure 2: Schematic representation of TIPs_IN candidate generation. 
A) Represents paired-end reads originated from the donor genome at the same location, with a 
size smaller than what to be expected within the human reference genome.  B) Represents the 
expected distance of the same read pairs within the human reference. 
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Processing & Filtering TIPs_IN Candidate List Data 
The candidate HERV lists produced by computational analysis was narrowed down by a number 
of specific criteria. The HERV-K candidates classified as members of the LTR5_Hs solo-LTR 
subfamily were the focus of this study due to the increased probability of activity (Taruscio & 
Mantovani, 1998). If the size of a candidate was less than 500 base pairs, it was assumed to be a 
fragment and not considered. Using the UCSC Genome Browser (http://genome.ucsc.edu/), the 
human genome was compared with those of two outgroups, in this case Pan troglodytes 
(chimpanzee) and Macaca mulatta (rhesus monkey), to ensure that the HERV insertion was not 
present in either of the genomes. If either outgroup species carried the insertion, then it was not 
considered a HERV, as it was inserted into an ancestral genome before the divergence of humans 
and chimpanzee. It was also essential to make certain that the regions flanking the candidate 
were unique, that is, they did not contain repeating elements (such as LINEs, SINEs, SNPs, etc.) 
so that primers could be designed specifically for that region of the genome. Additional criteria 
used include a minimal 5 pairs of reads supporting the same polymorphic pattern and the absence 
of the candidate insertion in one of the six genomes for TIPs_IN.  All of the selected candidates 
are found in   
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Table 2. 
Generation, processing, and filtering of Full-length TIPs_IN Candidate List 
 The full-length TIPs_IN candidate list represents HERV loci that are found within the 
human reference genome as a full-length insertion with a sequence similar to HERV-K113.  The 
initial candidate list was established by comparing the sequence identity of the HERV-K113 gag 
and env sequences published by (Belshaw 2005a, 12507) using the BLAT tool found at 
(http://dbrip.brocku.ca/cgi-bin/hgBlat?command=start).  The initial candidate list was composed 
of entries that were obtained using BLAT against the GRCh37/hg19 assembly of the human 
genome sequence, and found to have a sequence identity of 95% or greater.   
The initial full-length TIPs_IN candidate list was compared to the known polymorphic 
HERVs that had been previously published to keep those not studied before.  The list was further 
narrowed using the UCSC Genome Browser (http://genome.ucsc.edu/) to ensure their absence in 
the outgroup genomes and for primer availability as described in the previous section.  All of the 
selected candidates are found in Table 3. 
Generation and Filtering of TIPs_Out Candidate List 
 The TIPs_Out list of candidate polymorphic HERV loci represent insertions that were 
absent in the human reference genome but present in one or more of the donor human genomes.  
This candidate list was generated by Xuemei Luo in Dr. Liang’s lab via computational 
comparative genomics analysis using the same donor genome data set as the TIPs_IN 
predictions.  Below is a brief description of the computational algorithms and procedures used. 
The paired-end mapping sequences were aligned using the MAQ software.  This software 
labels concordant (mapped to the same chromosome) reads with a flag of 18 (MF18) and those 
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mapped to two different chromosomes with a flag of 32 (MF32 reads).  Based on the alignments 
of paired-end reads to the human reference genome, the MF32 reads provided the signatures for 
possible TIPs_Out candidates, by indicating an insertion is found within that region (Figure 3).  
These reads were then further required to have one of the reads mapped to non-repetitive region 
position and the other mapped to a HERV sequence.  The location for the transposons in the 
human reference genome was based on the RepeatMasker annotation obtained from the UCSC 
Genome Browser (http://genome.ucsc.edu).  Candidate reads were then clustered based on their 
positions on the reference genome where each cluster represented a candidate HERV insertion 
locus. The insertion genotype was then determined by comparing the ratio of concordant MF18 
reads to the MF32 reads.  A genotype of “+/+” required most paired-end reads in the region 
flanking the insertion to display an MF32 flag and very few or no concordant pairs (MF18); 
while the genotype for “+/-” show roughly half MF18 and MF32 reads.  Due to the alignment of 
paired-end reads, the size of the novel insertion was roughly predicted by adding the flanking 
region to the size of the LTR sequence the read was mapped to, but is not a reliable source of 
information. 
 
Figure 3: Schematic representation of TIPs_OUT prediction. 
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A reads has one read (A1) in the 5’ flanking region of the predicted TIP_OUT insertion and the 
other read (A2) mapping into a TE of the same subfamily elsewhere in the genome.  B reads 
(B2) has one read in the 3’ flanking region of the predicted insertion and other read (B1), 
mapped into the same TE elsewhere in the genome as A2.  
 
 The initial TIPs_OUT candidate list was narrowed by a number of very strict criteria 
while examining the predicted genotype data to minimize the possible false positives.   First, all 
of the entries that gave an uncertain genotype prediction for all 6 individual test samples were 
excluded, as the data associated with these entries was very poor.  The entries which gave an 
MF32/MF18 value of 0/0 for each of the 6 individual test samples were excluded, as these were 
likely to represent false positive insertions.  If the predicted genotype for all of the 6 individual 
test samples was predicted to be +/+ for an insertion, these were excluded because these would 
represent an insertion found in every individual, and therefore less likely to be polymorphic.  If 
the size of the candidate was less than 500 base pairs, it was assumed to be a fragment, and was 
excluded.  The candidate list was further narrowed to those with between 10-50 reads, as this 
represented the most likely number based on the sequencing coverage depth.  In order to narrow 
the remaining list, the list was filtered for candidates that were of high interest.  This included 
TIPs that were specific to either the Nigerian or Utah populations, as these would represent a 
polymorphic status, followed by checking primer availability in the flanking regions.  All of the 
selected candidates are listed in Table 4. 
Genome Position 
All of the TIPs_IN and TIPs_OUT candidate lists were generated from the March 2006 
NCBI36/hg18 assembly of the genome, whereas the full-length TIPS_IN were generated from 
the February 2009 GRCh37/hg19 assembly of the genome.  In order to make comparisons and 
avoid overlap between these lists, the genome position annotations were converted from one 
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version to another using the liftOver tool found on the UCSC genome browser website 
(http://genome.ucsc.edu/cgi-bin/hgLiftOver). 
DNA Test Samples 
The computational analysis of TIPs was done using the data from the six test DNA 
samples used in the first pilot of the 1000 Genomes Project, and the DNA from these individuals 
were purchased from the Coriell Biorepository.  The Coriell sample IDs for the trio family from 
Yoruba in Ibaden, Nigeria were NA19238 (mother), NA19239 (father) and NA19240 (daughter) 
and the Utah trio family were NA12892 (mother), NA12891 (father) and NA12878 (daughter) 
(Coriell 2011). These samples were used for genotyping using PCR to validate the computational 
prediction.  
To perform an extended allele frequency of those polymorphic insertions verified using 
the 6 trio samples, a 24-sample panel from Coriell’s Polymorphism Discovery Resource 
[M24PDR] was also used. The following samples come with no specific ethnicity data associated 
with each DNA sample, but are intended to cover a wide variety of population groups: 
NA15029, NA15036, NA15215, NA15223, NA15245, NA15224, NA15236, NA15510, 
NA15213, NA15221, NA15227, NA15385, NA15590, NA15038, NA15056, NA15072, 
NA15144, NA15216, NA15226, NA15242, NA15268, NA15324, NA15386 and NA15594 
(Coriell 2011).  In addition to these samples, for some loci with low allele frequency, two 
additional Coriell sample sets were used: the HD11 panel of Africans North of the Sahara 
samples: 17380, 17379, 17382, 17378, 17384, 17381, 17383 and the HD12 panel of Africans 
South of the Sahara samples: 17348, 17341, 17344, 17342, 17347, 17346, 17343, 17345, 17349 
(Coriell 2011).  Since there is no available sequencing data associated with these samples, they 
were genotyped based solely on PCR results.  Each of the stock DNA samples obtained from 
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Coriell were stored at -80°C, and 50ng/µl working solutions were created for each DNA sample 
by suspending in TE buffer solution (Tris 1M, EDTA 0.5M at pH 8.0) and stored at -20°C. 
Primer Design 
Primers were designed for the final polymorphic HERV insertion candidates using UCSC 
Genome Browser (http://genome.ucsc.edu/) and Primer3 online software 
(http://frodo.wi.mit.edu/primer3/). The UCSC Genome Browser was used to obtain the DNA 
sequence from the human reference genome in the locations of the predicted insertions.  For the 
TIPs_IN candidates, the primers were designed in the regions flanking the insertion that was 
present in the human reference genome, while trying to avoid being placed within another 
repetitive element (Figure 4A). The TIPs_OUT candidates do not have an insertion within the 
human reference genome; therefore these primers were designed in the regions that flanked the 
predicted chromosomal position acquired from the computational analysis (Figure 4B).  The 
DNA sequences obtained for each candidate location and surrounding flanking regions was used 
in Primer3 software to create primers using the following general primer picking conditions: 
Primer size minimum 18, optimal 20, maximum 27 bases, Primer melting temperature minimum 
57.0°C, optimal 60.0°C, maximum 63.0°C, and GC content between 40 and 70 percent.  The 
designed primers were tested using the UCSC Genome Browser’s In-Silico PCR program to 
ensure that one and only product at the expected locus and size is predicted in the human 
reference genome.  The information provided by the In-Silico PCR was used to determine the 
size of the alleles with and without the insertion. 
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Figure 4: TIPs_IN and TIPs_OUT primer design strategy. 
A) TIPs_IN forward and reverse primers are designed to flank the solo-LTR or the full-length 
HERV depending on the status within the human reference genome sequence.  Internal primers 
designed to be located in either the gag, env, 5’ LTR or 3’ LTR were used in conjunction with 
either the forward or reverse primers. B) TIPs_OUT forward and reverse primers are designed to 
flank the computationally predicted insertion location within the human reference genome 
sequence.   
 
It is difficult to genotype a full-length HERV (~9.5kb) using regular PCR due to the large 
product sizes.  To overcome this issue, “universal” primers were designed using the full-length 
HERV-K113 sequence that was published by (Belshaw 2005).  To aid in identifying full-length 
HERV insertions, primers were manually designed for amplifying the internal regions, 
specifically on the – strand within the gag region, and on the + strand within the env region of 
the HERV (see Table 5).  These primers are used to help determine the orientation of TIPs_OUT 
candidates, as well as confirming the presence of an LTR by using each of the “universal” 
primers is in conjunction with the forward and/or reverse primer designed for each candidate 
locus.  Some of the forward and reverse primers designed for the full-length HERVs found 
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within the literature were also ordered, along with previously designed internal and LTR primers.  
All of the primers were ordered from AlphaDNA (www.alphadna.com).  Each of the stock 
primers were stored at -20°C, and 10µM working solutions were suspended in TE buffer solution 
(Tris 1M, EDTA 0.5M at pH 8.0) and stored at -20°C. 
 
 
 
 
  
37 
 
Table 2: TIPs_IN candidate locations for which primers were designed 
Location 
(chr: s-e) 
TE 
Size 
(bp) 
Size 
+TE 
(bp) 
Size 
-TE 
(bp) 
Primer Sequences  
(5´-3´) TM(F/R) 
(°C) 
chr3:14107685-
14108653 
969 
 
 
1636 
667 F: aaagggcatggagaaatgtg 
R: cccacctaggctctgacttc 
59.9/58.9 
 
chr4:120483136
-120484102 
967 
 
1608 641 F: gaggtgtgcaagggacattt 
R: catccttcaaggccagaaaa 
60.0/60.2 
 
chr7:157722243
-157723211 
969 
 
1415 446 F: tgctcattcagaagccacac 
R: aacgagaagccagcatcagt 
60.0/60.0 
 
chr8:18695738-
18696706 
969 
 
1495 526 F: ctgcaggacgatgagaggat 
R: tatcatgccctgtggtctga 
60.4/60.1 
 
chr8:37170043-
37171011 
969 
 
1487 518 F: ctgggagagatggcagagag 
R: gcagtgagatgtggctttga 
60.1/60.0 
 
chr11:71155928
-71156598 
671 
 
846 175 F: ctggttcttcagagccacct 
R: cgactttgccttgaactgtg 
59.4/59.5 
 
chr12:54013481
-54014450 
970 
 
1449 479 F: ttcagtccctagaggtactatgctc
R: ggtttccagatcttaccagca 
59.4/59.2 
 
 
 
Table 3: Full-length TIPs_IN candidate locations for which primers were designed 
Location 
(chr: s-e) Hg19 
TE 
Size 
(bp) 
Size 
+TE 
(bp) 
Size 
-TE 
(bp) 
Primer Sequences  
(5´-3´) TM(F/R)
(°C) 
chr3:185281305-
185288547 
918
1 
9273 92 F:CATCCCTTCCATGCCTTAG 
R:GGGATTATGAGACAGGTACATG 
58.1/56.
0 
chr3:101411706-
101418889 
912
4 
1023
3 
110
9 
F: TCTCTGCAGGCTTGCAATC 
R: CCCACCCCAGATCCAAGTAC 
60.2/61.
5 
chr3:125610106-
125617634 
912
6 
9702 576 F: CTTACCAATGTGCCCACGTAC 
R: AGAGGCAGAATGATATGGTGGT 
60.3/59.
9 
chr8:140473118-
140475236 
309
0 
3517 427 F: TCCCACTGCCAAGAAGACC 
R: TCCCCCATCTTGCCTAGC 
61.2/61.
1 
chr10:6867110-
6874635 
946
3 
9737 274 F:GAGTTGGAGTGAGGAAATCAGTT
C 
R: GCATTACCTGCAGATACTCGTG 
60.5/59.
8 
chr10:101581556
-101587716 
705
4 
7231 177 F: CAGGTAGTAGCGTGGAGAAAAC 
R: CTTCACCCTCCATTCCAGG 
58.1/60.
4 
chr11:101566762
-101574290 
946
6 
9620 154 F: AAACACTTCCATGCTCAGAAAG 
R: CCATCCCTGGCAAAATGAC 
58.5/61.
3 
chr12:58722211-
58729730 
945
7 
1143
2 
197
5 
F: TGTTGGGGCTGAGGACAG 
R: CTACAGCTGCCCCATGATTAC 
60.8/59.
6 
chr21:19933917-
19940998 
830
5 
8778 473 F: CTGAACATGAATTCTTTGCAAG 
R: CTTGCAAAGAATTCATGTTCAG 
57.6/57.
6 
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Table 4: TIPs_OUT candidate locations for which primers were designed 
Location 
(chr: s-e) Hg18 
Size 
-TE 
(bp) 
Primer Sequences 
(5´-3´) 
TM(F/R) 
(°C) 
chr4:9590458-
9590900 
500 
 
F:ACCCTCCAGCTCCAGTGC 
R:GGGCATCTTTTCAAGACGTT 
61.4/59.2 
 
chr6:161190594-
161191142 
933 
 
F:ACCATGAAGCCAGAGAGAAAAT 
R:GTCGCCTTTCCTTGGTCTC 
59.2/59.8 
 
chr13:89540897-
89541416  
650 
 
F:TTGATAAAATTTGGACAAGAAGTCTC 
R:TGCATCATAATTGAATGCAAAA 
59.2/59.1 
 
chr14:89981676-
89981754 
837 
 
F:CCCTATGGATACGACCATCAC 
R:GCACCTGCTCTTTCTCTTCC 
59.1/59.2 
 
chr15:26103457-
26104092 
969 
 
F:GATCTTACCAGAACAAAACCCAT 
R:CGCTTTGGATTGCTAGTGTG 
58.4/59.5 
 
chr20:12350168-
12350569 
518 
 
F:GCCCTGTTGTAATAGGCATGA 
R:GCAAAGGAATTTGAGCCAAG 
60.0/59.8 
 
chr21:44526904-
44527067 
215 
 
F:CACGGCATGGTGGAAAGT 
R:GATGCCTTAGCCCAGAGATG 
60.5/59.8 
 
chr5:74942501-
74942793 
589 
 
F:GCTTTGAATACCCTCCCCAAT 
R:TGCACAGTGCTAAGGTTTGG 
61.4/59.9 
 
chr6:32565513-
32565534   
369 
 
F:AACAGAGAATGCCGTCAAATG 
R:TTGGGTTCACTTTATCCACCA 
60.1/60.2 
 
chr8:26596800-
26597248   
1015 
 
F:CATGGTGGGAATTTATCAACG 
R:CCATCTGGGAAGTGTGGAG 
60.1/59.0 
 
chr9:33120476-
33120527   
170 
 
F:GCTGGTGAGCTAAGGTCAGG 
R:CCACTCCCATTTGGCTTATG 
60.0/60.3 
 
chr9:71604561-
71604867   
1520 
 
F:CCCAAGGCAGAAAGTCTTAAG 
R:GGCTCTGGCTCCAATTACAC 
58.1/59.7 
 
chr11:124879106-
124879109 
257 
 
F:AAGGAAAACTGAGGACTGGTG 
R:CCCAAAAAGCAGCAGTTTGTA 
58.3/60.3 
 
chr12:11502680-
11503061  
759 
 
F:AAGGGTGGGGGAATACGTC 
R:CCTCACACATTTGCTTCTGC 
61.0/59.4 
 
chr14:50903129-
50903366 
849 
 
F:TCCTACTCTTGGGAGGCTCA 
R:AGCAAGGCACCAGGACTTAG 
59.9/59.5 
 
chr21:15966603-
15966908  
997 
 
F:CAGCTGCTGGGTGCTGAG 
R:TCAGCAGAACAATGAGTACAAGG 
62.0/59.4 
 
chr1:110110564-
110110730 
916 
 
F:GGGCATGTCCTTGAAATTGT 
R:CTCTTTCTTTTCCCCACAGG 
59.8/58.8 
 
chr16:79673433-
79673677 
638 
 
F:TGGAGCTTTGCATTGTTCTG 
R:AATAACGCAAGCCAGCAGAG 
60.0/60.5 
 
chr16:79687236-
79687414 
775 
 
F:CCCTAGGGCAAAGGCTACTC 
R:CATGTGGAAAGGAACCCAGT 
60.2/59.8 
 
chr1:16943334-
16943482 
342 
 
F:GCTGGGATTATAGGCACACG 
R:AAATTGTTCAAAAGCATCAAAGA 
60.5/58 
 
chr9:32849689- 456 F:TGTGTTTGTTTTGCGCATTT  
39 
 
32849840  R:TGAAAGGTGCATGCTCAGTC 
chr19:22205964-
22206428 
649 F:CGACACAAAGGAAGACACAGAG 
R:GACGGTTTTTGACTTAAGATAGAGC 
59.9/59 
 
chr1:225025914-
225026184 
600 F:TCAAACTCTAGCTCACATGTCCT 
R:GAAAACAATGGAGGGTGAGG 
58.1/59.4 
 
chr1:223336301-
223336671 
450 F: TTTCCCTTGATGTTCTTCCA 
R: CATTACCCTTCCATGAGAATCA 
58.1/58.9 
 
chr2:24987735-
24988289 
850 F: ACAGGCTCCGAGGGAAGATA 
R: TGTTACAGTTTAGTGCCTTCTGG 
61.1/58.5 
 
chr11:99317377-
99317663 
629 F: TACATGCATTCCCAGGGTTT 
R: TGACATGATTTTGCCTGACTCT 
60.2/59.6 
 
chr15:24169171-
24169651 
574 F: AGGCTGCTCAAGGCTACAGA 
R: GATTCAGGCTGTTTCGTGTG 
60.3/59.3 
 
chr17:10388873-
10389199 
487 F:TGCCACAAGTAGTTTAGATTGGTC 
R:TGAAGGAGAAGGTCCAGGAA 
59.6/59.8 
 
chr17:4959277-
4959821 
670 F: GCCAGTGAGCCTCTGACTTT 
R: CTCGAGGACCGCCTCAGT 
59.6/61.6 
 
chr17:24467429-
24467979 
651 F: GCCTCCACATTCCCTGAGTA 
R: ACTTCACTCTGAGGCGGTGA 
 60.1/61.0 
 
chr17:32220207-
32220618 
 
1477 
F: GACTGACTGTGCCCTTGGAT 
R: TGGAAAATTCAAGCAATATGGA 
 60.1/59.4 
 
 
 
Table 5: Universal internal HERV primers designed 
Primer Name HERV 
Locatio
n 
Primer  Distance 
from LTR 
(bp) 
Primer Sequence (5’-3’) TM 
(F/R) 
(°C) 
HERV_5LTR
_1  
5’LTR - 5' LTR   
922/3' LTR 
66  
GTGGGACGAGAGATTTGGA
A 60 
HERV_5LTR
_2  
5’LTR - 5' LTR  
776/ 3' LTR 
212  TTCTCAAAGAGGGGGATGTG 60 
HERV_5LTR
_3  
5’LTR - 5' LTR 845/   
3' LTR 143  GCGTTCAGCATATGGAGGAT 60.1 
HERV_3LTR
_1  
3’ LTR + 5' LTR 
776/3' LTR 
212 CACATCCCCCTCTTTGAGAA 60 
HERV_3LTR
_2  
3’ LTR + 5' LTR 
770/3' LTR 
238  TCCCCACAATTGTCTTGTGA 59.9 
HERV_3LTR
_3  
3’ LTR + 5' LTR 550/  
3' LTR 431 CCCGATTGTATGCTCCATCT 59.9 
HERV_Gag_1  gag - from 5'  TTTGCCAGAATCTCCCAATC 60 
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2175 
HERV_Gag_2  
gag - from 5'   
2248 TCGGACCTGTTCTTGTACCC 60 
HERV_Gag_3 
gag - from 5'  
2572  CTCAGGATTGGCGTTTTCAT 60.1 
HERV_Env_1 
env + from 3'  
1208 
 
AAATTTGGTGCCAGGAACTG 60 
HERV_Env_2  
env + from 3'  
1206 ATTTGGTGCCAGGAACTGAG 60.1 
HERV_Env_3  
env + from 3'  
1575 TGCTGTAGCAGGAGTTGCAT 59.6 
Barbulescu et al. 1999 LTR Primers 
LTR+_M1 
5’ LTR + 5' LTR  20 
/3' LTR 968 
TGTGGGGAAAAGCAAGAGA
G 60.4 
LTR+_M2 
5’LTR + 5' LTR  446 
/3' LTR 542 CTGTGCTGAGGAGGATTAGT 54.5 
LTR+_M3 
3’LTR + 5' LTR  849 
/3' LTR 139 TCCATATGCTGAACGCTGGT 61.6 
LTR+_M7F 
5’LTR + 5' LTR  342 
/3' LTR 646 AAGCCAGGTATTGTCCAAGG 59.1 
LTR+_M8F 
3’LTR + 5' LTR  821 
/3' LTR 167 
TAAGGGAACTCAGAGGCTG
G 59.4 
LTR-_M4 3’LTR - 5' LTR  940   GTGGGTGTTTCTCGTAAGGT 56.6 
LTR-_M5 
 - not found in 
K113 
sequence 
GGACAGGCAGGAGACAGAT
G 60.8 
LTR-_M6 
 - not found in 
K113 
sequence CTGAGTTGACACAGCACACG 59 
LTR-_M7R 
5’ LTR - 5' LTR  342 
bp CCTTGGACAATACCTGGCTT 59.1 
LTR-_M8R 
3’LTR - 5' LTR  821 
bp CCAGCCTCTGAGTTCCCTTA 59.4 
Full-length HERV from Barbulescu et al. 1999 
HERV-
K103_MB-
2_F 
  1508 total 
GATTTCGAGCCACCTCTGAA
G 61.3 
HERV-
K103_MB-
3_R 
  1508 total 
CTCAGAAACAGGCTTAAGAC
G 56.9 
HERV-
K109_MB-
23_F 
  9794 total 
GTCCTTTAATGTCTCCCCTC 55.2 
HERV-
K109_MB-
37_R 
  9794 total 
CAGATGAGATGTCAAGCAA
GGT 59.4 
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Full-length ERV from Belshaw et al. 2005 
s859c12_F 
   TAGGCTTGAGGTATAAGTCA
C 51.4 
s859c12_R 
   TTGGTTTCCAGATCTTACCA
GC 60.5 
 
 
PCR Genotyping  
 Genotyping and validation of the selected candidates was performed using PCR.  Each 
25µl PCR reaction was setup using Invitrogen’s AccuPrime™ Taq DNA Polymerase System kit 
reagents.  Each reaction was carried out in a sterile thin walled 0.25 ml PCR tube and composed 
of 2.5 µl 10x AccuPrime™ PCR Buffer II, 2.5 µl of each primer (10µM), 50 ng of the DNA 
sample of choice, 0.5 µl AccuPrime™ Taq DNA Polymerase, and 16.0 µl of autoclaved distilled 
water.  PCR reactions were run on Eppendorf Mastercycler or Mastercycler gradient (Eppendorf; 
Mississauga, Ontario) with the following protocol: 
Lid Temperature 95°C 
94°C 2 minutes 
*94°C 30 seconds     *35 cycles 
*54°C-60°C 30 seconds (depending on TM of primers)    
*68°C 1 minute 30 seconds – 4 minutes (depending on expected product size)      
68°C 10 minutes 
Hold 4°C upon completion 
 
PCR products were loaded on a 1%-2% agarose gel (depending on expected product size) 
stained with ethidium bromide or RedSafe™ Nucleic Acid Staining Solution (iNtron 
Biotechnology, Toronto, Ontario).  Each agarose gel was then subjected to electrophoresis (45 
minutes-90 minutes at a voltage of 75V-110V, depending on the size of the gel) in 1x TAE 
buffer and visualized by exposing to UV light using a BioRad Gel Doc 1000 with a camera.  
Each PCR amplification product was compared against the Invitrogen 100 bp DNA Ladder (Cat 
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# 15628-050), Invitrogen 1 Kb Plus DNA Ladder (Cat #10787-018) or Norgen Biotek 
LowRanger 100 bp DNA Ladder (Cat# 11500) depending on the expected product size. 
Possible Genotypes for Each Individual DNA Sample 
Traditionally throughout the literature there are three possible genotypes used to identify 
a polymorphic HERV insertion (Moyes 2007).  Throughout this study more allele combinations 
were observed  throughout the screening of all 30 individual DNA samples.  This has led to the 
proposal of using six possible allele combinations to describe the genotype of HERV insertions 
(Table 6).  The first combination is the Pre-integration site on both alleles with no HERV 
insertion present on wither allele (abbreviated as PI/PI).  The second possible combination is a 
solo-LTR being present on one allele, and the pre-integration site with no HERV insertion on the 
other allele (abbreviated PI/sLTR).  The third combination is the presence of a full-length HERV 
insertion on one allele and the pre-integration site with no HERV insertion on the other allele 
(abbreviated (PI/FL).  The fourth possible combination is the presence of a solo-LTR on both 
alleles (abbreviated sLTR/sLTR).  The fifth possible combination is the presence of a solo-LTR 
on one allele and a full-length HERV insertion on the other allele (abbreviated sLTR/FL).  The 
sixth and final possible combination is the presence of a full-length HERV insertion on both 
alleles (abbreviated FL/FL). 
 
Table 6: Possible allele combinations and their allele genotype abbreviation 
Possible Allele Combinations Allele Genotype 
Abbreviation 
Both Pre-integration Alleles PI/PI 
Pre-Integration and Solo-LTR Allele PI/sLTR 
Pre-integration and Full-length Allele PI/FL 
Both Alleles Solo-LTR sLTR/sLTR 
Solo-LTR and Full-length Allele sLTR/FL 
Both Full-length Alleles FL/FL 
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Given that there are six genotype combinations that are possible for each locus, these are 
likely to result in a variation of genotypes throughout multiple individuals as a result of 
Mendelian inheritance.  This has led to three possible categories for which to classify the overall 
genotype status for each HERV locus that has been tested (Table 7).  The first category is 
dimorphic, which results from at least two individuals with a different genotype at a given locus.  
This is further broken down into three sub-categories.  The first sub-category is a dimorphic 
solo-LTR, which is used to describe the presence of only the pre-integration allele and solo-LTR 
genotype combinations occurring within all of the tested individuals at that locus.  This can occur 
with one individual having both pre-integration alleles and another individual having the pre-
integration allele and the solo-LTR allele or both solo-LTR alleles.  The second sub-category is 
dimorphic Solo-LTR and Full-length, which is used to describe the presence of only the solo-
LTR allele and the full-length allele genotype combinations occurring within all individuals at 
that locus.  This can occur when one individual has both solo-LTR alleles and another individual 
has both full-length alleles.  This can also occur when one individual has one solo-LTR allele 
and one full-length allele while another individual has either both full-length alleles or both solo-
LTR alleles.  The third sub-category is dimorphic full-length, which occurs when only the pre-
integration allele and the full-length allele are present in all of the individuals at that locus.  This 
can occur when one individual has both pre-integration alleles and another individual has both 
full-length alleles.  This can also occur when one individual has one pre-integration allele and 
one full-length allele while another individual has both pre-integration alleles or both full-length 
alleles.   
 The second category is trimorphic, which is used to describe the presence of the pre-
integration allele, solo-LTR allele and full-length HERV insertion allele within at least two 
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individuals at that locus.  This can occur in four different combinations.   The first combination 
occurs when one individual having both pre-integration alleles while another individual has one 
solo-LTR allele and one full-length allele.  The second combination occurs when one individual 
has one pre-integration allele and one solo-LTR allele while the other individual has one pre-
integration allele and one full-length allele.  The third and fourth combinations occur when one 
individual has one pre-integration allele and one solo-LTR allele while the other individual has 
both full-length alleles or both solo-LTR alleles.   
 The third category is fixed, which is used to describe either a solo-LTR allele or full-
length HERV insertion allele that is homozygous in all individuals within a locus.  They are 
categorized as fixed because with a homozygous genotype in all individuals this insertion pattern 
will not change as a result of Mendelian inheritance, but can only change through unrelated 
insertions/deletions within that locus. 
 
Table 7: HERV locus classification categories, sub-categories and their corresponding 
genotypes 
HERV Locus 
Classification Category 
Locus Classification 
Sub-Category 
Genotypes Required in at Least One 
Individual at that Locus 
 
 
 
Dimorphic 
Dimorphic Solo-LTR PI/PI and PI/SLTR 
PI/PI and sLTR/sLTR 
 
Dimorphic Solo-LTR 
and Full-length 
sLTR/sLTR and FL/FL 
sLTR/sLTR and sLTR/FL 
sLTR/FL and FL/FL 
Dimorphic Full-
length 
PI/PI and PI/FL 
PI/PI and FL/FL 
 
            Trimorphic 
PI/PI and sLTR/FL 
PI/sLTR and PI/FL 
PI/sLTR and FL/FL 
sLTR/sLTR and PI/FL 
Fixed Fixed Solo-LTR All show sLTR/sLTR 
Fixed Full-length All show FL/FL 
 
 
45 
 
TIPs_IN PCR Genotyping Strategy 
 The TIPs_IN candidate list is composed of computationally predicted solo-LTRs that are 
present within the human reference genome sequence, but predicted to be absent from one or 
more of the six test individuals.  Therefore for each candidate to be considered polymorphic, the 
solo-LTR must be absent in one or more individuals.  To test for these polymorphisms, first the 
F+R primer was run using the DNA sample with the best prediction data showing the absence of 
the solo-LTR insertion.  If this sample showed the absence of the solo-LTR insertion, the F+R 
was run on the panel of 6 test sample individuals, followed by the panel of 24 anonymous 
individuals.  Although this data shows the presence and absence of a solo-LTR, it does not give 
any information with regards to the presence of a possible full-length HERV insertion.  To test 
for a full-length insertion, each candidate was first checked in the UCSC Genome Browser to 
determine the orientation of the solo-LTR insertion.  With this information the “universal” 
internal primers were tested along with the appropriate flanking primers for each candidate 
insertion’s orientation.  By overlaying all of these images, it is possible to compare each 
individual and identify the pre-integration band, solo-LTR band, and full-length bands to 
determine a complete genotype.  In the cases where the internal primers showed non-specific 
amplification with the flanking primers, the “universal” 5’ or 3’LTR primers were run with the 
corresponding flanking primer, to see if any samples that showed the absence of a solo-LTR 
band during initial screening, resulted in amplification of the flanking and LTR primer 
combination.  These cases are listed as potentially full-length insertions, as they have not been 
fully validated with the internal primers. 
Given that the full-length TIPs_IN candidates are present within the human reference 
genome sequence, in order to be polymorphic, these candidates must be found as either a solo-
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LTR or absent from an individual.  Because they were found within the reference genome this 
allowed access to a variety of information using the UCSC genome browser, such as: HERV 
orientation, size of insertion, In-Silico testing of both the flanking primers, as well as the 
flanking primers combined with the “universal” internal primers.  This information was obtained 
for all of the full-length TIPs_IN candidates prior to PCR genotyping.  Unlike the other TIPs_IN 
candidates, these insertions were not computationally predicted to be polymorphic, so there were 
no DNA samples for which the insertion was predicted to be absent.  Therefore to test these 
candidates, a 50 ng/µl mixture of the 24 anonymous DNA samples was created for preliminary 
testing of these candidates.  To test for the absence of the full-length insertion, the F+R primers 
were run to check for amplification of either a pre-integration band or a solo-LTR.  If either of 
these two bands were present, these candidates were run on both the panel of 24 anonymous 
individuals, followed by the  panel of 6 individuals.  Although screening the candidates with the 
mixed DNA proved effective in some candidates, in cases where the polymorphism is present in 
very few individuals, amplification of these bands were either very faint or not visible. The 
flanking primers were also run with the internal primers selected from the In-Silico testing to 
determine if the full-length insertion was absent from any of the test individuals.  By overlaying 
these gel images, it is possible to identify a complete genotype for each individual. 
TIPs_OUT PCR Genotyping Strategy 
Unlike the TIPs_IN candidates, the TIPs_OUT candidates are absent from the human 
reference genome; and to be polymorphic must appear as either a solo-LTR or a full-length 
insertion in one or more of the test individuals.  The only information available before screening 
the TIPs_OUT candidates was the computationally predicted location of each insertion within 
the human reference genome sequence.  Therefore the first step in testing each of the candidates 
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was to run a PCR (using the DNA sample with the best prediction data), which consisted of 3 
separate reactions, F+R primers, F+5’ LTR primers, and F+3’LTR primers.  By running this 
combination of primers, it was possible to identify whether or not a solo-LTR existed in this 
sample (from the F+R), and determine the orientation of the HERV insertion (by comparing the 
F+5’LTR and F+3’LTR).  If the F+R showed a solo-LTR, this was run on the panel of 6 
individuals, followed by the panel of 24 anonymous individuals.  Using the candidate’s insertion 
orientation, the “universal” internal primers were tested along with the appropriate flanking 
primers on the DNA sample with the best prediction data.  Although this worked in some cases, 
the universal primers will not work if only the solo-LTR is present in the sample.  Therefore the 
“universal” internal primers were also tested with the mixed DNA to identify a working 
combination.  If a combination of internal primers worked, they were run on the 6 panel of test 
sample individuals, followed by the 24 panel of anonymous individuals.  In the cases where a 
suitable internal primer could not be found, the F+5’ or 3’ LTR primer combination used in the 
initial screening was run on the panel of 6 test sample individuals, followed by the panel of 24 
anonymous individuals.  By overlaying these gel images, it was possible to identify any 
individuals that did not have a solo-LTR band, but the LTR primer worked, thus indicating a 
possible full-length insertion.  These specific individuals were then used to test the flanking 
primers combined with the “universal” internal primers to find a suitable combination for testing 
on the panel of 6 test sample individuals, and the panel of 24 anonymous individuals.  By 
overlaying these gel images, it is possible to identify a complete genotype for each individual. 
PCR and Sample Preparation for DNA Sequencing 
The samples selected for sequencing were those that represented a novel pre-integration 
site or insertion sequence as a way of further validation and characterization.  Samples from 
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candidates of interest (trimorphic status etc.) were also sequenced to allow for comparisons of 
the LTR sequences between multiple individuals.  Each sample sent for sequencing was first 
amplified in a 50µl PCR reaction as described in the PCR genotyping section above.  All of the 
selected PCR products were purified using the Norgen Biotek PCR purification kit or Gel 
purification kit following the manufacturer’s instructions (Norgen Biotek Corp; St. Catharines, 
Ontario), followed by DNA concentration determination, and if necessary dilution to obtain a 
concentration between 30 and 100 ng/μl before sending for sequencing at The Centre for Applied 
Genomics (TCAG) in the Hospital for Sick Children in Toronto, Ontario.   All sequencing was 
done on the Applied Biosystems 3760XL DNA Analyzer.   
PCR Genotype Data Analysis  
 PCR results for all of the candidates were examined for evidence of insertional 
polymorphisms as demonstrated by the variation in the size of the product in at least one test 
sample.  Each of these candidates were used to calculate and compare the expected and observed 
allele frequencies as follows: 
Observed Allele Frequency =                  # of the allele              _ 
                 Total # of alleles in population 
 
   
Using the Hardy-Weinberg equilibrium (p2 + 2pq + q2 = 1), the genotype frequencies can be 
calculated, where: 
p = allele frequency of PI present = # of alleles/total # of alleles in population 
q = allele frequency of sLTR present = # of alleles/total # of alleles in population 
 
In the case of 3 allele combinations being present, this must be expanded to: 
p2 + q2 + r2 +2pq + 2pr + 2qr = 1 
r = allele frequency of FL present = # of alleles/total # of alleles in population 
 
The expected frequencies are calculated as: 
Expected p = allele frequency of PI present x total individuals genotyped 
Expected q = allele frequency of sLTR present x total individuals genotyped 
Expected p = allele frequency of FL present x total individuals genotyped 
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Estimation of proviral ages by LTR sequence comparisons 
Given the abundance of ERVs in primate genomes, they are ideal candidates for 
exploitation as phylogenetic markers (Johnson, Coffin 1999).  The relative age of ERVs can be 
estimated by comparing the sequences of the two LTRs.  Due to the mechanisms behind reverse 
transcription, the two LTRs are identical at the time a provirus forms.  Any mutations that 
accumulate over evolutionary time will be unique to one of the two LTRs, thus allowing the 
estimation of the proviral age (Turner 2001).  The current accepted rate of mutation was 
developed by dividing the number of substitutions per site between the human and chimpanzee 
ERV sequences, by the age of the most common ancestor of humans and chimpanzees (~4.5 
million years ago).  This gives an estimated mutation rate of 2.3x10-9 to 5.0x10-9 substitution per 
site per year (Johnson, Coffin 1999).  Given that the average HERV-K LTR is 970 bp long, this 
gives an estimate of approximately one difference per LTR every 200,000-450,000 years (Turner 
2001).  Due to the imprecise estimates of divergence dates found throughout the literature, these 
calculations can only provide a rough estimate of absolute time, but they are still very useful for 
comparing the relative ages and rates of evolution of different HERV loci (Johnson, Coffin 
1999).  In the scenario where only a solo-LTR allele is present, this type of analysis cannot be 
completed as the second LTR is not available.  Instead, it is possible to compare the solo-LTRs 
of multiple individuals at the same locus to estimate the time that those individuals diverged 
from one another.  This can also give a very rough indication of how long ago the solo-LTR was 
formed.   
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Results 
 
Verifying TIPS_IN solo-LTR Candidates using Trio Samples and Anonymous 24 
Individual Samples 
From the list of computationally generated TIPs_IN candidates for HERV insertions, 7 loci were 
chosen to be verified and genotyped by PCR based on the selection criteria outlined in the 
Materials and Methods section (  
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Table 2).  Each candidate was tested on the two trio family samples from which the 
insertion prediction was made.  Each of these candidates exists as a solo-LTR within the human 
reference genome, and therefore a polymorphic status is obtained by verifying the absence of this 
insertion within at least one haploid test genome.  In addition to validating the absence of an 
insertion, this PCR assay allowed the determination of the genotype for each individual sample. 
All of the 7 candidate loci tested were verified to be polymorphic using the 6 trio 
samples, demonstrating a 100% accuracy of the computational prediction.  These loci were 
subjected to further analysis using a panel of 24 anonymous diverse human DNA samples for 
surveying their frequency in the human populations.  Since these loci were presented as solo-
LTRs in the reference genome, we also checked to see whether a full-length LTR was present in 
any of the samples used in this study. For this purpose, we used the “universal” primers for LTR 
internal viral regions designed based on the internal region of the full-length HERVK, that are 
close to the LTR sequences, i.e. the gag and env genes, in combination with the primers designed 
in the region flanking the insertions.  These primer combinations between the internal primers 
and the flanking primers were first tested on individuals that were homozygous with the PI 
alleles during the initial screening, since an apparent “homozygous” PI genotype can be obtained 
for samples carrying a PI/FL genotype due to the failure of amplifying the full-length LTR. The 
same is true for samples showing an apparent homozygous sLTR genotype.  The combinations 
of internal primers with flanking primers only amplified in one locus, chr12:54013481-
54014450, indicating the presence of the FL allele.  By overlapping the images produced from 
the F+R, F+HERV_GAG_1 and R+HERV_ENV_3 primers, the full genotype of each individual 
locus can be determined.  From the panel of 6 test individuals (Figure 5A), NA19238 was 
heterozygous for the sLTR and FL alleles.  NA19239 remained homozygous with the PI alleles.  
52 
 
NA12892 was found to be homozygous with the FL alleles.  The remaining individuals were all 
found to be heterozygous with the PI and FL.  When the same primer combinations were used to 
screen the 24 sample panel (Figure 5B), 4 individuals (NA15233, NA15245, NA15224, 
NA15226) were shown to be heterozygous for the sLTR and FL, 3 individuals (NA15236, 
NA15385, NA15038) were heterozygous for PI and sLTR, 3 individuals (NA15510, NA15227, 
NA15242) were homozygous with the FL, one individual (NA15386) that was homozygous for 
the sLTR.  The remaining 8 samples were all found to be heterozygous with the PI and FL.  
Based on the co-presence of the PI, sLTR and FL alleles among the individuals tested, this 
insertion is shown to be a novel case of trimorphic HERV-K. 
 
 
A) B)  
Figure 5: PCR genotype results for the combination of the F+R, F+GAG_1 and R+ENV_3 
primers on candidate chr12:54013481-54014450. 
A) Result for the 6 trio individuals.  B) Results for the 24 human diversity panel. The sizes of the 
pre-integration band and sLTR alleles are 479 bp and 1449 bp respectively.  
 
Candidate locus chr11:71155928-71156598 was shown to be heterozygous with the PI 
and sLTR alleles in all 30 of the individuals tested (Figure 6).  In theory this is not impossible, 
but it is highly improbable based on Hardy-Weinberg equilibrium that a heterozygous allele 
combination will become fixed within a population, as there should be some individuals 
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homozygous for the insertion as well as some homozygous insertion-free.  Although the sample 
size tested is extremely small compared to the entire human population, the individuals tested are 
supposed to represent the major human ethnic populations.  Therefore more individuals must be 
tested before this candidate locus can be classified as a fixed PI/sLTR insertion.  Based on the 
presence of the PI and sLTR alleles among the individuals tested, this insertion has been 
categorised as dimorphic PI/sLTR.  This may also be a result of PCR contamination. 
A) B)  
Figure 6: PCR genotype results for the combination of the F+R primers on candidate 
chr11:71155928-71156598. 
A) Result for the 6 trio individuals.  B) Results for the 24 human diversity panel. The sizes of the 
pre-integration and sLTR alleles are 175 bp and 897 bp, respectively. 
 
The other 5 candidate loci only showed the presence of different combinations of the PI 
and sLTR alleles throughout the samples tested.  All of these were all classified as dimorphic 
PI/sLTR.  An example of this genotype status is illustrated with chr3:14107685-14108653 in 
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Appendix 1 – TIPs_IN Positive Results and all results summarized in  
 
 
 
 
 
 
 
 
 
 
 
Table 8: Summary of TIPs_IN candidate loci PCR genotyping. With the 24 sample panel, 
only one test sample  (NA15224) did not amplify either the PI or sLTR.  To ensure this was not a 
result of a failed PCR reaction, this sample was run a second time, with the same result.  Since 
neither band amplified, this sample was further tested with all of the internal primers to 
determine if a full-length insertion was present.  All of the internal primers did not amplify with 
the proper size, or as a single band (non-specific amplification).  Therefore this sample is likely 
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not amplifying the PI or sLTR due to either a mutation in the primer binding site or a possible 
deletion of this region within this individual genome.   
In summary, of the 7 candidates, 6 were classified as dimorphic PI/sLTR after 
genotyping, due to the presence of both the PI and sLTR among the individuals tested, while 
locus, chr12:54013481-54014450 was shown to be trimorphic based on the presence of all three 
possible alleles (PI, sLTR and FL).  The full-length HERV allele identified here adds to a very 
short list of full-length HERV-K sequences outside the human reference genome sequences. 
Further, our results suggest that for a HERV insertion that is shown in the reference genome as a 
solo-LTR and dimorphic in some sample, it is very likely a full-length version can still exist in 
the human population.   
A)  B)  
Figure 7: PCR genotype results for the combination of the F+R primers on candidate chr. 
3:14107685-14108653. 
A) Result for the 6 trio individuals.  B) Results for the 24 human diversity panel. The size of the 
pre-integration band is 667 bp, and the size with the insertion is 1636 bp. 
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Table 8: Summary of TIPs_IN candidate loci PCR genotyping 
 Number of Individuals with Each Genotype 
(Observed/Expected) 
 
Candidate 
Position 
Insertion 
Status 
Sample 
Size 
PI/PI PI/ 
sLTR 
PI/
FL 
sLTR/
sLTR 
sLTR/
FL 
FL/
FL 
Observed 
AF  
PI/sLTR 
/FL 
chr3:14107685
-14108653 
Dimorphic 
PI/sLTR 
30 0/0.1 4/3.9 0 25/25.
9 
0 0 0.07/0.93/
0 
chr4:12048313
6-120484102 
Dimorphic 
PI/sLTR 
30 5/ 
10.1 
25/ 
14.6 
0 0/5.3 0 0 0.58/0.42/
0 
chr7:15772224
3-157723211 
Dimorphic 
PI/sLTR 
30 18/19.
2 
12/9.6 0 0/1.2 0 0 0.8/0.2/0 
chr8:18695738
-18696706 
Dimorphic 
PI/sLTR 
30 17/ 
15.98
716.0 
10/ 
11.8 
0 3/2.2 0 0 0.73/0.27/
0 
chr8:37170043
-37171011 
Dimorphic 
PI/sLTR 
30 0/6.6 28/ 
14.9 
0 2/8.4 0 0 0.47/0.53 
chr11:7115592
8-71156598 
Dimorphic 
PI/sLTR 
30 0/7.5 30/15 0 0/7.5 0 0 0.5/0.5/0 
chr12:5401348
1-54014450 
Trimorphic 30 3/3.1 3/3.8 10/ 
9.2 
1/1.2 7/5.8 6/6
.9 
0.32/0.2/0.
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Verifying Full-Length TIPS_IN HERV-K Candidates using the Trio Samples and 
Anonymous 24 Individual Samples 
There were a total of eight FL TIPs_IN candidates chosen to be genotyped by PCR based 
on the selection criteria outlined in the Materials and Methods section (Table 3).  Each of these 
candidates exists as a full-length insertion within the human reference genome, and therefore a 
polymorphic status can be confirmed by verifying either the presence of sLTR or the absence of 
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this insertion within at least one haploid test genome using a strategy similar to the ones used in 
genotyping TIPs_IN solo-LTRs. As polymorphic status of these loci were not predicted in any 
particular individual, each candidate locus was tested on both the 6 trio-individuals and the 24 
sample panel.  Of the eight candidate loci tested, five were found to only contain the full-length 
insertion, as no sLTR or PI could be amplified in any of the test individuals, thus are categorised 
as Fixed FL-HERV-K.  The genotype images for the five candidates that appeared to be fixed FL 
insertions can be found in the   
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Appendix 2 – FL TIPs_IN Positive Results. 
A) B)  
Figure 8: PCR genotype results for the combination of the F+R, F+GAG_1 and R+ENV_2 
primers on candidate chr8:140473118-140475236. 
A) Result for the 6 trio individuals.  B) Results for the 24 human diversity panel. The sizes of the 
FL fragment band and the F+ENV_2 band are 3517 bp and 1230 bp, respectively. 
 
 Two of the eight candidates tested were found to be dimorphic.  For candidate 
chr3:185281305-185288547, four of the 30 individuals tested (NA19238, NA15215, NA15056, 
NA15268) were found to be heterozygous with the sLTR and FL, with the rest being 
homozygous for the FL allele.  Based on the presence of the sLTR and FL alleles among the 
individuals tested, this insertion has been categorised as dimorphic sLTR/FL.  The genotype 
image for this candidate can be found in   
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Appendix 2 – FL TIPs_IN Positive Results.  Candidate chr3:125610106-125617634 was found 
to be heterozygous with the PI and FL alleles in all 30 of the individuals tested.  Again this is not 
impossible, but it is very improbable that this genotype would be found in the entire population 
as in the case of chr11:71155928-71156598 described earlier.  This again may indicate 
contamination of the PCR.   
Interestingly, locus chr11:101566762-101574290 was shown to be trimorphic by having 
the FL-LTR, sLTR and PI allele detected in the 30 samples (Figure 9).  This becomes the second 
trimorphic HERV-K insertion identified in this study, increasing the total number of trimorphic 
HERV-K insertions ever identified to three (Belshaw 2005).  This also indicates that for any full-
length HERV-K to be documented in the human reference genome, there is a chance to find a 
dimorphism of PI and FL and even trimorphism. 
A) B)  
Figure 9: PCR genotype results for the combination of the F+R, F+GAG_1 and R+ENV_2 
primers on candidate chr11:101566762-101574290. 
A) Result for the 6 trio individuals.  B) Results for the 24 human diversity panel. The sizes of the 
pre-integration band and F+GAG_1 band are 2249 bp and 1286 bp, respectively 
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In summary, a polymorphic status was identified for 3 of the 8 full-length HERVK loci 
tested, with one being dimorphic with the PI and FL alleles, another being dimorphic with the 
sLTR and FL alleles, and a third being a trimorphic case (Table 9: Summary of Full-length 
TIPs_IN candidate loci genotyping).  For the 5 loci (chr3:10, chr8, chr10, chr21) that appear to 
show a fixed FL insertion, it may suggest that these insertions occurred relatively early and have 
certain advantage by maintaining in the full-length status, thus have had the chance to spread 
over all human populations an extremely high frequency. However, a PI allele may be later 
found when more diverse samples, especially samples from old population, are analyzed. In the 
same time, a sLTR allele of this insertion may be generated in future generations via 
recombination. 
 
Table 9: Summary of Full-length TIPs_IN candidate loci genotyping 
 Number of Individuals with Each Genotype 
(Observed/Expected) 
 
Candidate 
Position 
Insertion 
Status 
PI/PI PI/ 
sLTR 
PI/FL sLTR/
sLTR 
sLTR/
FL 
FL/FL Observed 
AF 
PI/sLTR/ 
FL 
Chr3:18528130
5-185288547 
Dimorphic 
sLTR/FL 
0/0 0 0 0/0.1 4/3.9 26/ 
25.9 
0/0.07/0.9
3 
Chr3:10141170
6-101418889 
Fixed FL 0 0 0 0 0 30 0/0 /1 
Chr3:12561010
6-125617634 
Dimorphic 
PI/FL 
0/7.5 0 30/15 0 0 0/7.5 0.5/0/ 
0.5 
Chr8:14047311
8-140475236 
Fixed FL 
Fragment 
0 0 0 0 0 30 0/0/1 
Chr10:6867110
-6874635 
Fixed FL 0 0 0 0 0 30 0/0/1 
Chr11:1015667
62-101574290 
Trimorphic 0/0.1 1/2.2 3/1.7 7/8.1 16/12.
8 
3/5.0 0.07/0.52/
0.41 
Chr12:5872221
1-58729730 
Fixed FL 0 0 0 0 0 30 0/0/1 
Chr21:1993391
7-19940998 
Fixed FL 0 0 0 0 0 30 0/0 /1 
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*All candidates that were homozygous for all individuals tested were excluded from the 
expected allele frequency (AF) calculations as there was not enough data available to calculate 
this. 
 
Verifying TIPS_OUT candidates using the trio samples and anonymous 24 
individual samples 
In addition to the above polymorphic HERV-K insertions identified based on those 
present in the human reference genome sequences, we also explored the use of the newly 
available personal genome sequence data to identify novel HERV-K insertions not present in the 
reference genome.  For this, 29 candidate loci were selected for genotyping from a larger list of 
computationally predicted TIPs_OUT HERV insertions, which was based on the analysis of the 
personal genome data of the 6 trio samples from the 1000 Genome Project, using criteria 
outlined in the Materials and Methods section (Table 4).  Each candidate was first tested on the 
two trio-family samples from which the insertion prediction was based on.  Each of these 
candidates exists as a pre-integration site within the human reference genome.  Therefore a 
polymorphic status is obtained by verifying the presence of either a solo-LTR or full-length 
insertion. 
Using a PCR design similar to the screening of the TIPs_IN, of the 29 candidates tested, 
6 were found to be dimorphic PI/sLTR.  Of these six loci, chr4:9590458-9590900 exhibited a 
very low insertion rate, with only one (NA19238) individual of the 30 tested having a 
heterozygous PI/sLTR insertion and all remaining 29 samples being homozygous for the PI 
allele (Figure 10). Although none of the internal universal primers were able to amplify the FL 
allele, the possibility that any of these might actually be PI/FL cannot be excluded.  This 
candidate was further tested on the HD 11 panel of Africans North of the Sahara and the HD 12 
panel of Africans South of the Sahara.  Of these 23 individuals tested, only one other (NA17348) 
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also displayed a heterozygous PI/sLTR insertion, while all remaining samples shown as 
homozygous for the PI alleles.  This extremely low frequency of this sLTR allele suggests that 
this insertion is likely to be fairly recent and limited to certain Nigerian/African populations.  
However, a much larger sample size is needed to confirm this. Due to its extreme low allele 
frequency and presumably very recent insertion, it is reasonable to expect the likelihood of 
identifying the presence of a full-length allele by screening more individuals in the related 
populations 
A) B) 
C) D)  
Figure 10: PCR genotype results for the combination of the F+R primers on candidate 
chr4:9590458-9590900. 
A) Results for the 6-sample panel.  B) Results for on the 24-sample panel. C) Results for HD 11 
panel of Africans North of the Sahara.  D) Results for the HD 12 panel of Africans South of the 
Sahara.  The size of the PI band is 500 bp, and the sLTR band is roughly 1500 bp. 
 
 
The genotype data of the other five candidates which were also found to be dimorphic 
PI/sLTR are provided in   
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Appendix 3 – TIPs_OUT Positive Results and summarized in Table 10.  Among these, 
locus chr6:161190594-161191142 was shown to have a high frequency with 21 of the 30 
individuals being homozygous with the sLTR, and 8 being heterozygous (NA12892, NA12891, 
NA15223, NA15224, NA15385, NA15590, NA15216, NA15242) with the PI/sLTR, and only 
one being homozygous for the PI (NA12878).  By allele frequency, this is followed by locus 
chr13:89540897-89541416 for which 23 of the 30 individuals were homozygous with the PI 
alleles, and 7 (NA19238, NA19239, NA19240, NA15221, NA15144, NA15216, NA15268) were 
heterozygous with the PI/sLTR, and by locus chr20:12350168-12350569, chr21:15966603-
15966908 and chr17:4959277-4959821.  
To search for the presence of a full-length allele for each locus in samples with an 
apparent homozygous PI or sLTR genotype, which include the previous 6 loci and remaining 
loci for which no sLTR was detected, universal internal primers were used as described earlier.  
One difference in this case is that due to their absence in the reference genome, the orientation of 
the insertions was uncertain unlike in the case of TIPs_IN insertions, because this was not 
included as an output of the prediction data. Therefore, two possible combinations between the 
internal primers and the flanking primers were needed to be tested.  One candidate, 
chr19:22205964-22206428 was showed to be dimorphic with the PI/FL alleles (Figure 11).  In 
this case, the F+R combination of primers showed that all 6 individuals were homozygous with 
the PI, but the F+3LTR_1 amplified a product with the correct size for the presence of a full-
length insertion in NA19239, NA19240 and NA12892, leading to their genotype of heterozygous 
PI/FL, and indicating that this insertion was in – strand orientation. These primers were then run 
on the 24 panel anonymous individuals where 7 individuals (NA15029, NA15223, NA15224, 
NA15213, NA15221, NA15590, NA15268) were homozygous with the FL, 6 individuals 
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(NA15036, NA15215, NA15242, NA15385, NA15038) were homozygous with the PI, and the 
remaining 11 individuals were heterozygous with the PI and FL.  Based on the presence of only 
the FL alleles among the individuals tested, this insertion has been categorised as dimorphic 
PI/FL, and it represents a novel full-length HERV insertion outside of the reference genome.  
A) B)  
Figure 11: PCR genotype results for the combination of the F+R primers on candidate 
chr19:22205964-22206428. 
A) Result for the 6 trio individuals.  B) Results for the 24 human diversity panel. The size of the 
PI band is 646 bp, the LTR band is ~550 bp and the GAG band is ~1850 bp. 
 
 
Two candidates, chr6:32565513-32565534 and chr11:124879106-124879109, were 
found to have a polymorphic PI allele that only amplified in some the 30 individuals tested, 
whereas the rest of the individuals showed no amplification with F+R, as well as combination of 
internal primers with flanking primers.  The PCR results of chr6:32565513-32565534 is shown 
in Figure 12. To ensure the absence of amplification was not due to operation-error resulted PCR 
failure, PCR was repeated and the result ended up being the same. A likely explanation for this 
scenario is that a mutation/deletion may have occurred in the primer sites and prevents PCR from 
working in some individuals. One way to determine whether a full-length insertion is present as 
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homozygous FL genotype is to run a long-range PCR with F+R primers.  This was performed by 
a colleague and no amplification was observed.   
 
A) B)  
Figure 12: PCR genotype results for the combination of the F+R primers on candidate 
chr6:32565513-32565534. 
A) Result for the 6 trio individuals.  B) Results for the 24 human diversity panel.  The size of the 
PI band is 369 bp. 
 
Table 10: Summary of positive TIPs_OUT candidate loci PCR genotyping 
 Number of Individuals with Each Genotype 
(Observed/Expected) 
 
Candidate 
Position 
Insertion 
Status 
Sampl
e Size 
PI/P
I 
PI/sLT
R 
PI/F
L 
sLTR/sLT
R 
sLTR
/FL 
FL/FL Observed 
Allele 
Frequency 
PI/sLTR/FL
chr4:9590458
-9590900 
Dimorphic 
PI/sLTR 
44 42/ 
42.3 
2/1.7 0 0/0.01 0 0 0.98/0.02/0 
chr6:1611905
94-
161191142 
Dimorphic 
PI/sLTR 
30 1/ 
0.9 
 
8/ 
8.5 
0 21/20.7 0 0 0.17/0.83/0 
chr13:895408
97-89541416 
Dimorphic 
PI/sLTR 
30 23/ 
23.2 
7/6.3 0 0/0.4 0 0 0.88/0.12/0 
chr20:123501
68-12350569 
Dimorphic 
PI/sLTR 
30 27/ 
27.1 
3/2.9 0 0/0.08 0 0 0.95/0.05/0 
chr6:3256551
3-32565534 
Polymorphic 
PI 
30 16 0 0 0 0 0 0.53/0/0 
chr11:124879
106-
124879109 
Polymorphic 
PI 
30 17 0 0 0 0 0 0.57/0/0 
chr21:159666
03-15966908 
Dimorphic 
PI/sLTR 
30 24/ 
24.3 
6/5.4 0 0/0.3 0 0 0.9/0.1/0 
chr19:222059
64-22206428 
Dimorphic 
PI/FL 
30 9/ 
8.4 
0 14/ 
14.9 
0 0 7/6.6 0.53/0/0.47 
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chr17:495927
7-4959821 
Dimorphic 
PI/sLTR 
30 28/ 
25.9 
2/3.9 0 0/0.1 0 0 0.93/0.07/0 
 Insertion 
Prediction 
Accuracy 
24.1% 
*All candidates that were homozygous for all individuals tested as well as those with a 
polymorphic pre-integration site were excluded from the expected allele frequency (AF) 
calculations as there was not enough data available to calculate this.  This table excludes all of 
the candidates that were not shown to be polymorphic. 
 
Based on these PCR result, a polymorphic status was verified for 7 of the 29 loci tested 
with their genotype results summarized in Table 10.  Despite the presence of the sLTR, it should 
be noted that for individuals representing a genotype of “PI/PI” the possibility of the genotype 
actually representing “PI/sLTR” cannot be excluded due to the preferential amplification of the 
smaller product.  Also in the instances where the only polymorphic genotype was shown as 
PI/sLTR or those with a polymorphic PI, the possibility of those with the genotype “PI/PI” or no 
amplification at all actually representing the genotype “PI/FL” cannot be excluded as the 
“universal” internal primers did not always amplify with one clear product.  In these instances, 
due to the non-specific amplification, these primer combinations were not used to determine a 
FL insertion as it became too subjective to classify which product band reflected the FL 
insertion.  Therefore these candidates should be considered for further screening in the future. 
Combined Results of Polymorphism Survey from this Study 
 Overall in this study we were able to identify a total of 17 novel polymorphic 
insertions ( 
Table 11).  Of these confirmed candidates, 12 were classified dimorphic PI/sLTR.  One was 
classified dimorphic sLTR/FL, and two were dimorphic PI/FL.  Interestingly 2 candidates were 
found to exhibit a trimorphic status.  An additional 4 candidates were found to be a fixed FL 
insertion.  Overall this study indicates that the level of HERV polymorphism is much higher than 
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previously demonstrated in the published literature (Barbulescu, Turner et al. 1999, Turner 2001, 
Costas 2001, Hughes 2004, Belshaw 2005). 
 
 
Table 11: Total number of candidates found within this study and their corresponding 
insertion status 
Insertion Status Number of Candidates Confirmed 
In This Study 
Dimorphic PI/sLTR 12 
Dimorphic sLTR/FL 1 
Dimorphic PI/FL 2 
Trimorphic 2 
Fixed FL 4 
Total Confirmed 
Polymorphic Loci 
 
17 
 
Sequence Data Analysis 
A total of seventeen loci were chosen to be sequenced based on the presence of one or 
two alleles outside the human reference genome sequence, thus representing novel sequences. 
Such alleles can be the pre-integration allele for insertion present in the reference genome, the 
sLTR allele for a FL in the reference genome or the FL allele for insertion reported as sLTR in 
the reference genome.  Out of those sequenced, only twelve were of high enough quality to 
properly assemble and analyse.  The sequence data was used to construct a complete sequence of 
the insertion along with the flanking sequences and target site duplications (TSDs) by comparing 
the sequences of the pre-integration allele and the insertional allele.  The target-site duplication, 
as a hallmark of retrotransposition, represents the additional sequence rearrangements caused by 
a HERV-K insertion. Also importantly the availability of the detailed sequence allows the 
definitive confirmation of the computational prediction and PCR genotyping result.  An example 
of a novel sequence is provided in Figure 13, while the remaining sequences have been 
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submitted to GenBank (http://www.ncbi.nlm.nih.gov/genbank/); accession numbers can be found 
in Table 12. 
 
 
 
 
>NA_19238|locus: hg18:chr6:161190427-161191359, insertion site: 
chr6:161190896, classification: LTR5_Hs 
ACAGTGAACACAGAGAAAAGATGATGGTACACCCAGAGAAAAGATGATGGTACGCCgcctgtgg
ggaaaagcaagagagatcagattgttactgtgtctgtgtagaaagaagtagacataggagactc
cattttgttctgtactaagaaaaattcttctgccttgagattctgttaatctataacctcaccc
ccaaccccgtgctctctgaaacatgtgctgtgtcaaaatcagagttaaakggattaagggcggt
gcaagatgtgctttgttaaacagatgcttgaaggcagcatgctccttaagagtcatcaccactc
cctaatctcaagtacccagggacacaaaaactgcggaaggccgcagggacctctgcctaggaaa
gccaggtattgtccaaggtttctccccatgtgatagtctgaaatatggcctcctgggaagggaa
agacctgaccgtcccccagcccgacatccgtaaagggtctgtgctgaggaggattagtgaaaga
ggaaggaatgcctcttgcagttgagacaagaggaagtcatctgtctcctgcccgtccctgggca
atggaatgtctcggtataaaacccgattgtatgctccatctactgagatagggaaaagccacct
tagggctggaggtgggacctgcgggcagcaatactgctttgtaaagcattgagatgtttatgtg
tatgcatatctaaaagcacagcacttaatcctttacattgtctatgatgcaaagacctttgttc
acgtgtttgtctgctgaccctctccccacaattgtcttgtgaccctgacacatccccctyttcg
agaaacacccacagatgatcaataaatactaagggaactcagaggttggcgggatcctccatat
gctgaacgctggttcccccggtccccttatttctttctctatactttgtctytgtgtctttttc
ttttccaaatctytcgtccccccttacgagaaacacccacaggtgtggaggggcaacccacccc
tacaTACGCCCAGAGAAAAGACGACATTGCACCCAGAGAAAAGATGACAGTGAACCTAGA 
Figure 13: Detailed sequence and annotation of solo-LTR insertion at locus 
chr.6:161190427-161191359 subjected to DNA sequencing. 
The sequence is presented in fasta format.  The UPPER CASE sequence indicates the 
flanking/pre-integration sequence, while the lower case represents the solo-LTR insertion 
sequence and the TSDs are underlined.  The information about the sample ID, original locus ID 
based on genomic location of the region represented by the flanking sequence in the hg18 
reference genome, the exact insertion site, and the HERV subfamily designation are provided in 
the sequence description line. 
 
In all cases, the sequencing result matches with the predicted loci positions, and validated 
the genotype result.  This is based on the match of sequences flanking the involved HERV 
insertion within the human reference genome.  The availability of the pre-integration and 
insertion allele enables very accurate identification of TSD sequences.  
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Table 12: Type of novel sequences obtained for each candidate, and their target site 
duplication. 
Candidate Type of TIP Sequence 
Obtained 
DNA 
Sample 
Target Site 
Duplication (TSD) 
GenBank 
Accesion 
# 
chr3:14107685 TIPs_IN 
(sLTR) 
Pre-
integration 
Site 
NA19238 AGAAGA  Pending 
chr3:125610106 FL_TIPs_ 
IN 
Pre-
integration 
Site 
NA19238 TGTGG Pending 
chr6:161190594 TIPs_OUT 
 
Solo-LTR NA19238 TACGCC Pending 
chr7:15772224 TIPs_IN 
(sLTR) 
Pre-
integration 
Site 
NA19238 CACTCTGC Pending 
chr8:18695738 TIPs_IN 
(sLTR) 
Pre-
integration 
Site 
NA19238 ATGAAGC Pending 
chr8:37169884 TIPs_IN Pre-
integration 
Site 
NA19240 GATTTT Pending 
chr11:71155870 TIPs_IN Pre-
integration 
Site 
NA19238 CCCTC Pending 
chr11:101566762 FL_TIPs_ 
IN 
Solo-LTR NA19238 ATTGTGT Pending 
chr11:101566762 FL_TIPs_ 
IN 
Pre-
integration 
Site 
NA19240 ATTGTGT Pending 
chr12:54013481 TIPs_IN 
(sLTR) 
Pre-
integration 
Site 
NA19239 TAAAA Pending 
chr13:89540897 TIPs_OUT Solo-LTR NA19238 CTACTT Pending 
chr20:12402168 TIPs_OUT Solo-LTR NA19238 AAGTGG Pending 
 
As the two LTRs flanking the proviral insertion upon integration are identical initially, the 
sequence divergence found between the 5’ and 3’LTRs of HERVs can serve as a molecular clock 
for estimating the ages of the insertion (Dangel, Baker et al. 1995). Using the LTR sequence 
divergence, the age of the full-length HERV proviral sequences found within the Hg19 human 
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reference genome were estimated by comparing the sequence divergence between the 5’ and 3’ 
LTR (  
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Table 13).  The upper bound was generated using the inferred evolutionary rate specific 
to HERV LTR of 1.3x10-9 mutations/site/year, resulting in a divergence rate of 0.13% per 
million years (My) as determined by Lebedev et al. 2000.  This rate was generated by comparing 
the LTR sequence divergence of orthologous ERVs in different species and factoring in the time 
passed since these species diverged (Lebedev, Belonovitch et al. 2000).  The lower bound was 
generated using the inferred mammalian genome rate of 2.2x10-9 mutations/site/year, resulting in 
a divergence rate of 0.22% per My as determined by Kumar and Subramanian 2002.  This 
boundary was chosen as this rate has been reported as relatively invariant within and between 
primate genomes, thus representing the most conservative age estimation (Kumar, Subramanian 
2002). The age estimates placed the overall insertion time of these HERV proviruses between 
1.4-23 million years.  It is highly unlikely that the estimates above 5 million years are accurate, 
as the human and chimpanzee lineages are thought to have diverged between 4-6 my ago 
(Buzdin, Lebedev et al. 2003).  The remaining estimates ranging from 1.4-3.18 million years, 
agree with previous studies done with HERV-K (Dangel, Baker et al. 1995, Jha, Pillai et al. 
2009, Subramanian, Wildschutte et al. 2011), furthering the evidence that these are the youngest 
subgroup of HERVs. 
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Table 13: Age estimation of full-length HERV insertions by comparing the sequence 
divergence between the 5’ and 3’ LTRs. 
Candidate Position 
Hg19 
#SNPs 
between 5’ 
and 3’ LTR 
# Transitions 
/Transversions
% Sequence 
Variation 
Lower 
Boundary 
(Kumar and 
Subramanian 
2002) My 
Upper 
Boundary 
(Lebedev 
2000) My 
Chr3:185281305-
185288547 
3 3/0 0.31 1.409 2.384 
Chr3:101411706-
101418889 
15 9/6 2.77 7.036 11.91 
Chr3:125610106-
125617634 
16 14/2 2.05 9.312 15.759 
Chr10:6867110-
6874635 
29 24/5 3.3 13.6 23.02 
Chr11:101566762-
101574290 
4 4/0 0.41 1.878 3.179 
Chr12:58722211-
58729730 
4 4/0 0.41 1.878 3.179 
*Million years (My) 
 
 Given a solo-LTR does not have a second LTR to compare to, their ages have mainly 
been overlooked in all of the previous studies.  Subramanian et al. 2011 however, have proposed 
estimating the age of a solo-LTR by comparing it to the subgroup consensus sequence generated 
from the alignment of all known sLTRs in the human reference genome.  This estimate was 
normalized to an average of 3.4x10-9 mutations/site/year, resulting in a sequence divergence of 
0.34% per million years (Subramanian, Wildschutte et al. 2011).  Using this estimate as an upper 
bound, the age of all polymorphic sLTRs identified in this study (with quality sequence data) 
were estimated (see Table 14).  The lower bound of 0.22% per My as determined by Kumar and 
Subramanian (2002) was used to reflect a relatively conservative mutation rate.  All of the solo-
LTR sequences were determined to be from the LTR5_Hs subgroup, and this consensus 
sequence was used for all of these sequence comparisons.  Only the SNPs and 1bp 
insertion/deletions were factored into the sequence divergence, as larger insertions/deletions do 
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not accurately reflect a point mutation, and can severely skew the age estimates. The age 
estimates for the polymorphic insertions range from 1.8 million years to 7.9 million years.  These 
estimates coincide with the estimated time of divergence between the human and chimpanzee 
lineages, and agrees with other published sLTR estimates (Buzdin, Lebedev et al. 2003, 
Subramanian, Wildschutte et al. 2011).  This reveals that all of these insertions are very young 
with regards to evolutionary timeframes, furthering the evidence that the HERV-K subgroup has 
been active most recently. 
Table 14: Age estimation of HERV-K solo-LTR by comparing the sequence divergence 
between polymorphic loci identified and the LTR5_Hs consensus sequence. 
Candidate 
Position Hg18 
#SNPs 
compared to 
LTR_Hs 
consensus 
sequence 
# Transitions 
/Transversions
% Sequence 
Variation 
Lower 
Boundary 
(Subramanian 
2011) My 
Upper 
Boundary 
(Kumar and 
Subramanian 
2002) My 
Chr3:14107685-
14108653 
12 8/4 1.24 3.646 5.635 
Chr4:120483136-
120484102 
9 8/1 1.14 3.342 5.165 
Chr7:157722243-
157723211 
8 7/1 0.83 2.431 3.757 
Chr8:18695738-
18696706 
10 8/2 1.03 3.038 4.696 
Chr8:37170043-
37171011 
6 5/1 0.62 1.823 2.817 
Chr11:71155928-
71156598 
10 10/0 
 
1.47 4.338 6.704 
Chr12:54013481-
54014450 
12 11/1 1.34 3.946 6.098 
Chr6:161190594-
161191142 
17 10/7 1.76 5.165 7.983 
 
 
Functional Impact of polymorphic HERVs Based on Gene Context 
To predict the functional impact each of the verified polymorphic loci was compared to 
the UCSC Genome Browser to determine the gene context of these insertions.  If an insertion 
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was within 2kb of any genes, it is considered as genic, otherwise as intergenic.  Of the 17 
polymorphic candidates identified, 12 were found to be intergenic.  The low number of HERV 
insertions within or near gene regions is expected, as these are more likely to reduce fitness and 
become excised or inactivated (Kurth 2010).  Intergenic insertions are less likely to have a 
definitive functional impact on genes due to their distance from the gene. However, they may 
also exert impact on genes via interfering distant gene regulatory sites or epigenetic regulation.  
Among the 5 insertions located within gene regions, 4 are in the intron region and 1 in the down 
stream region.  Interestingly, all of these insertions were found to be oriented anti-sense 
compared to the gene transcription, which provides support to the theory that HERV integrations 
within the intron are more likely to be found in the anti-sense direction due to selective pressure 
(Illarionova, Vinogradova et al. 2007, Doxiadis, De Groot et al. 2008).  
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Table 15: Gene context for all of the insertionally polymorphic HERVs identified in this 
study 
Candidate Position 
HG18 
Insertion Status Gene Context 
Chr3:14107685-
14108653 
Dimorphic 
PI/sLTR 
Intergenic 
Chr4:120483136-
120484102 
Dimorphic 
PI/sLTR 
Intergenic 
Chr7:157722243-
157723211 
Dimorphic 
PI/sLTR 
intron:PTPRN2:NM:002847 
Chr8:18695738-
18696706 
Dimorphic 
PI/sLTR 
intron:PSD3:NM:206909 
Chr8:37170043-
37171011 
Dimorphic 
PI/sLTR 
Intergenic 
Chr11:71155928-
71156598 
Dimorphic 
PI/sLTR 
Intergenic 
Chr12:54013481-
54014450 
Trimorphic ~790bp downstream of 
OR6C3 
Chr3:185281305-
185288547 
Dimorphic 
sLTR/FL 
Intergenic 
Chr3:125610106-
125617634 
Dimorphic 
PI/FL 
Intergenic 
Chr11:101566762-
101574290 
Trimorphic Intergenic 
Chr4:9590458-
9590900 
Dimorphic 
PI/sLTR 
intron:SLC2A9:NM:0010012
90 
Chr6:161190594-
161191142 
Dimorphic 
PI/sLTR 
Intergenic 
Chr13:89540897-
89541416 
Dimorphic 
PI/sLTR 
Intergenic 
Chr20:12350168-
12350569 
Dimorphic 
PI/sLTR 
Intergenic 
Chr21:15966603-
15966908 
Dimorphic 
PI/sLTR 
Intergenic 
Chr19:22205964-
22206428 
Dimorphic 
PI/FL 
Intergenic 
Chr17:4959277-
4959821 
Dimorphic 
PI/sLTR 
intron:ZNF232: 
NM:014519.2 
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Discussion 
 
 HERV-K shows evidence of being active since the divergence of humans and 
chimpanzees, but to date there have been no replication competent endogenous HERVs 
identified (Brady, Lee et al. 2009).  This had led to the widespread belief that HERVs have very 
limited to no current activity level within the human genome.  The availability of multiple human 
genome sequences has led us to examine the current activity level of HERVs.  The identification 
of HERVs has been previously been achieved by detecting ERV containing clones in BAC 
libraries using high-stringency hybridization with retrovirus-derived probes or synthetic primer 
binding sites; followed by PCR amplification of the novel ERV sequences from host genomic 
DNA (Gifford, Tristem 2003).  These methods were extremely time consuming and plagued by 
limitations without having the full human genome sequence.  Since the first publication of the 
human reference genome (Lander 2001, Venter 2001), and the increase in the more recently 
published personal genome data (Altshuler, Lander et al. 2010), the methods for identifying 
retrotransposon and HERV insertions have changed considerably and become much more 
efficient.   Computational comparative genomics has become the method of choice for 
identifying retrotransposon insertions by comparing individual genomes to the human reference 
genome (Wang, Song et al. 2006, Stewart, Kural et al. 2011, Hormozdiari, Alkan et al. 2011).  
This method allows a much more efficient way (with both cost and time) to identify potential 
insertion candidates, but is limited by the quality and sequence read lengths of the genome 
sequence data generated by the next generation sequencing technologies.  Given these limitations 
and the relative infancy of these prediction algorithms, this method of prediction is bound to 
generate false positive results, and therefore must be validated experimentally. 
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Evaluating approaches for discovering novel polymorphic HERV insertions 
In this study, we explored three different approaches to identify novel polymorphic 
HERV-K insertions.  Each of the three prediction methods used to identify polymorphic loci in 
this study proved fruitful, although with varying degrees of success.  Using a broad panel of 
individual DNA samples, the FL TIPs_IN method allowed the survey of FL HERV-K insertions 
found within the human reference genome that shared a 95% or higher sequence similarity to the 
HERV-K113 sequence.  This survey revealed that three of the eight loci tested are insertionally 
polymorphic, with the PI or sLTR alleles found in at least one test individual.  
The other two methods relied entirely on the computational comparison of individual test 
genomes to the human reference genome.  All seven of the TIPs_IN candidates were shown 
to be polymorphic, as the sLTR found within the human reference genome was proven to 
be absent in at least one haploid test genome ( 
 
 
 
 
 
 
 
 
 
 
 
Table 8).  Given that the insertion was present in each candidate initially, this leads to the 
assumption that the full-length HERV-K retroviral element parent copy was active during 
early human migration before the divergence of different ethnic groups.  When comparing 
all of the predicted genotypes for each donor genome with those obtained experimentally ( 
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Table 8), it was found that only 28.6% were correct.  This indicates that although this 
method did produce 100% accuracy for predicting a polymorphic locus at each candidate 
position, it is highly inaccurate for predicting the genotype of an individual sample. 
In contrast, only 7 of the 29 candidates predicted using the TIPs_OUT method were 
verified to be polymorphic; as the sLTR or FL alleles were found in at least one of the haploid 
test genomes whereas only the pre-integration site was present within the human reference 
genome (Table 10). Six of the seven polymorphic candidates were classified as dimorphic 
PI/sLTR as these two alleles were present among the individuals tested.  Only one of the 7 
verified polymorphic candidates was found to be heterozygous with the PI/FL alleles.  There 
were two candidates (chr6:32565513-32565534, chr11:124879106-124879109) that did not 
show any sLTR or FL alleles, but the pre-integration site appeared polymorphic among the 30 
individuals tested, as it was absent in 14 and 13 individuals respectively.  Due to the absence of 
the PI, the most likely explanation for this observed phenomenon is that these individuals have a 
mutation within the primer annealing site.  This would render the primers incapable of 
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amplifying this target region.  Another explanation could be the possibility of a FL allele existing 
within the target region, which a normal PCR is unable to amplify due to the large size (~10kb).  
There were no “universal” primers that amplified without non-specific amplification, so there 
was no evidence provided from this study supporting any FL alleles.  The PCR verification of 
the TIPs_OUT candidate list demonstrates 24.1% accuracy for the computational prediction of 
the polymorphic loci candidates that were selected (ie. with 75.9% false positives) (Table 10).  
The actual false positive rate from the computationally generated results is likely to be much 
higher than this, as the tested candidate list was heavily screened during the selection process and 
not randomly chosen.  Therefore this accuracy rate can only reflect the candidates chosen, and 
should not be applied to the entire list that was initially generated.   Although the genotype 
prediction was 100% correct for 3 of the candidates tested in each of the 6 individuals from the 
trio samples, the combined prediction accuracy of the computational algorithm was only 52.4% 
correct.  This number can be misleading, as one candidate’s genotype was not predicted correctly 
in any of the 6 individuals from the trio samples (0%), and two other candidate’s genotypes were 
only predicted correctly in 1 of the 6 samples (16.7%).  Therefore the prediction accuracy overall 
appears to be either very accurate, or very inaccurate for the candidates that were verified.  
Although this method generated a very high rate of false positives, some of these results may in 
fact represent a positive result that was not observed due to the limitations of the PCR 
verification for FL alleles.  One of these limitations is the PCR reagents themselves, which are 
limited to a maximum amplification size of ~5kb (Life Technologies 2010), which is only half of 
the FL HERV insertion length.  In these instances the use of a long range PCR reagent kit may 
allow the amplification of the FL allele, as they can amplify fragments up to ~12kb (Life 
Technologies 2010).  This method however would be limited by the presence of a pre-integration 
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site allele or sLTR allele, causing the PCR to preferentially amplify the smaller product, leading 
to the potential of the FL allele to amplify with far fewer copies, and may appear faint or not at 
all when visualized on the agarose gel after electrophoresis.  This is also the case in some of the 
individuals that were found to be homozygous with the PI alleles during a normal PCR reaction.  
The sLTR may actually be present, but given that the PI will preferentially amplify, the sLTR 
may not be visible on the agarose gel, resulting in a false indication of the genotype.  In instances 
where the sLTR appeared to amplify very faint, each of the samples were re-tested in order to try 
and limit the occurrence of this phenomenon as much as possible throughout this study.  The 
second limitation was the use of the “universal” internal and LTR primers.  All of these primers 
were designed using an alignment of the known FL HERV-K insertions that are present in the 
human reference genome, and were designed within the most conserved areas.  The 
computational prediction did not provide the predicted orientation of the insertion, resulting in 
this information to be gathered by testing combinations of the flanking primers with the 
“universal” LTR primers.  In some instances the LTR primers did amplify, but as the size of the 
product can only be estimated, the possible correct size became a large range, with no guarantee 
that the product was actually amplifying from the target site.  In the instances where the 
combination of a flanking primer and a “universal” LTR primer appeared to be within the correct 
size range, that individual sample was tested using all of the “universal” internal primers (in the 
gag and env genes) that were available using the orientation information provided from the LTR 
primer tests.  If any of the primer annealing sites had any mutations, these primers may not 
amplify the target site.  The fact that these “universal” primers are designed separately from the 
flanking primers also does not guarantee the proper efficiency, and these primers may not work 
as well together as those generated in pairs.  These scenarios can lead to either no amplification 
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or non-specific amplification of the target site.  Given all of these complications, it is possible 
that the rate of FL alleles in the candidate list may actually be higher than was able to be verified 
in this study. The third possible limitation could be attributed to the primer design using the 
human reference genome.  Since the TIPs_OUT candidates reflect insertions that are absent in 
the human reference genome but present in one of the haploid test genomes; more insertions are 
likely to be found in the Nigerian population, as the human reference genome is derived from 
mostly Caucasian DNA.  It is also possible that the genomic sequence from the Nigerian trio 
samples have more sequence divergence in the primer annealing sites than are found within the 
human reference genome.  This would lead to a higher rate of PCR failure in these individuals or 
the anonymous individuals which are closely related to this population group.   
The major reason that there are so many false positives with the TIPs_OUT prediction is 
related to the method of prediction using paired-end reads.  All of the current next generation 
sequencing technologies are limited by short read lengths and the accuracy of base calls, making 
the assembly of the whole genome from this raw data much more difficult.  The largest sequence 
library size that are available from the 1000 Genome Project are only 250bp (with a standard 
deviation of 100bp) which is still very far from the 10kb size of a FL HERV insertion, and the 
~970bp sLTR.  If the read lengths could be increased to create a library size large enough to span 
the entire size of the insertion, the accuracy of the computational would be increased 
monumentally. 
Although the TIPs_IN methods allowed the identification of a greater number of 
polymorphic loci, these methods are limited to the number of insertions found within the human 
reference genome.  Therefore although these methods have produced the largest number of 
results, there are only a finite number of polymorphic loci that can be discovered using these two 
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methods.  In contrast, the TIPs_OUT method produced a much smaller number of true 
polymorphic loci, but this method is theoretically capable of detecting an infinite number of 
polymorphic loci, as it is only limited by the number of genomes available to compare to the 
human reference genome.  Therefore as next generation sequencing technologies improve read 
lengths; the prediction accuracy of this method is bound to improve, and should be considered 
the method of choice for future discovery as it represents an unlimited number of potential 
polymorphic loci.   
Redefining current classification nomenclature for documenting HERV insertion 
polymorphism 
 Overall, a regular RE insertion is limited to two possible combinations including the 
presence of the RE allele, or the absence of the RE allele.  This has provided the basis of RE 
insertion polymorphism nomenclature, in which the presence of both the presence and absence of 
the RE insertion (PI) leads to a dimorphic classification of that RE insertion.  Although HERVs 
are REs, the LTR class for which they belong increases the variability found within this group of 
polymorphism.  Traditionally there have been three possible genotypes used to identify a 
polymorphic HERV insertion, which were originally proposed by Moyes et al. (2007).  These 
include the absence of the HERV allele (PI), the presence of a FL HERV allele, or the sLTR 
allele which occurs as a result of the homologous recombination of the FL provirus LTRs 
(Moyes 2007). Throughout this study we have observed the frequent presence of additional 
forms of genotypes for these HERV insertions, and we propose for the first time the use of 6 
types of genotypes to reflect all possible combinations of the PI, sLTR and FL alleles.  As shown 
in Table 6, the six genotypes of a HERV insertion locus include PI/PI, PI/FL, FL/FL, PI/sLTR, 
sLTR/sLTR, sLTR/FL.  In the context of polymorphism for the entire human population, any 
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locus showing a genotype of PI/FL and/or PI/sLTR are considered to be polymorphic by the 
standard insertion polymorphism criterion, which applies to all non-LTR TE insertions.  In 
addition, we argue that a locus showing a genotype of sLTR/FL, which may be in co-presence 
with sLTR/sLTR or FL/FL in the populations, should also be considered polymorphic by the 
definition of sequence polymorphism, since it means that there are clearly two different alleles 
for the same locus with one being sLTR and the other being FL, with these two combinations 
differing in sequence length by several kilo-bases, but both exist within the human population 
(Table 7). 
Polymorphic loci sequence analysis 
Since all of the polymorphic candidates were found by comparing to the human reference 
genome, it was important to obtain the DNA sequences for all novel alleles.  For the TIPs_IN 
candidates these are represented by the PI and FL alleles, whereas for the FL_TIPs_IN they are 
represented by the PI and sLTR.  The TIPs_OUT novel sequences are represented by the sLTR 
and FL alleles.  These sequences provide the ultimate validation of the computational prediction 
of insertion polymorphism with complete or partial sequence, as well as the exact location of the 
insertion within the human reference genome.  In all cases examined, the novel PI allele 
sequences matched those of the sequences flanking the HERV insertions found within the human 
reference genome.  This indicates that these are true polymorphic insertions, and are not the 
result of the HERV proviral loss due to a recombination event involving a non-orthologous locus 
containing a sequence similar to that flanking the provirus.  If this were the case the sequences 
flanking the provirus would likely have been mutated, resulting in a sequence difference between 
the flanking sequence and the PI sequence obtained (Turner 2001).  All of the PI sequences were 
compared to the HERV insertion allele sequences and the target site duplications were noted in 
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the PI sequence, also providing the exact location of each insertion within the human genome 
sequence (Table 12).    
 Using the candidates from the FL_TIPs_IN, representing the FL insertions found within 
the human reference genome, the 5’ and 3’ LTR sequence data was exploited in an attempt to 
estimate the age of these insertions (  
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Table 13).  Given that the sequence of the 5’ and 3’ LTR that flank the proviral genes are 
identical upon integration as a result of retrotransposition, each sequence will evolve 
independently.  Therefore the divergence between the two LTR sequences can serve as a 
molecular clock of the integration time by comparing to the proposed rates of sequence 
mutations.  For this study an upper bound was generated using the inferred evolutionary rate 
specific to HERV LTR of 1.3x10-9 mutations/site/year, resulting in a divergence rate of 0.13% 
per million years (My) as determined by Lebedev et al. (2000).  The lower bound was generated 
using the inferred mammalian genome rate of 2.2x10-9 mutations/site/year, resulting in a 
divergence rate of 0.22% per My as determined by Kumar and Subramanian 2002, as this 
represented a more conservative estimate.  Using these methods the youngest FL insertion tested 
was found to be chr3:185281305-185288547 with an age of 1.4-2.4 million years, whereas the 
oldest insertion was chr10:6867110-6874635 with an age of 13.6-23.02 million years ( 
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Table 13).  The older the insertion is, the more likely those alleles will become fixed within the 
population, as it is more likely to incur mutations which preventing the homologous 
recombination between the 5’ and 3’ LTRs.  It is important to note that the age estimates for 
chr3:101411706-101418889, chr3:125610106-125617634, chr10:6867110-6874635 are severely 
skewed by the high number of transitions.  It has been proposed that transitions occur roughly 5-
10 fold more often than transversions, and therefore these candidates may not follow the 
proposed molecular clock trends (Johnson, Coffin 1999).  When comparing the estimated age to 
the polymorphic status of these insertions, the oldest insertions (ranging from 9.3-23.02 million 
years) are all fixed FL within the samples tested, with the exception of chr12:58722211-
58729730 which deviates from this pattern.  This candidate was found to be fixed FL within all 
the samples tested, yet it appears to be only 1.87-3.17 million years.  Jha et al. (2011) also found 
discordance with insertion age and fixation, suggesting the probability of an ERV fixation may 
be inversely correlated with local chromosomal recombination rate and local gene density.  If 
this is the case, then a low rate of recombination in the region surrounding this insertion may 
have led to the acceleration of its fixation.  It is also possible that areas with a high rate of 
recombination will decelerate the fixation of the insertions that are older (Jha, Nixon et al. 2011). 
Aside from this exception, the younger insertions (ranging from 1.4-3.2 million years) have not 
yet become fixed within the population. 
 Similar age estimates were applied to the polymorphic solo-LTRs found throughout this 
study.  Unlike the FL estimates that rely on divergence of the two LTRs, the solo-LTR can only 
be compared to the LTR subgroup consensus; which was the LTR5_Hs consensus sequence 
(Subramanian, Wildschutte et al. 2011).   The upper bound of 0.34% per million years, or 
3.4x10-9 mutations/site/years as proposed by Subramanian et al. (2011) was chosen as it is the 
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only sLTR sequence divergence rate found within the literature.  As a lower bound the 0.22% per 
My as determined by Kumar and Subramanian 2002 was chosen as it reflected a more 
conservative estimate.  Using these age estimates, the youngest sLTR insertion was found to be 
chr8:37170043-37171011 with an age of 1.8-2.8 My, whereas the oldest insertion 
chr6:161190594-161191142 was found to be 5.2-7.9 My old.  When comparing the sLTR allele 
frequencies in association with their estimated ages, there does not appear to be any direct trends, 
which may be a result of the relatively young ages of these insertions with regard to evolutionary 
timeframes.  The age estimates for the FL and sLTR loci do however coincide with previous 
studies, furthering the evidence that the LTR5_Hs group have been continuously integrating into 
the germline since the divergence of humans and chimpanzees roughly 4-6 my ago 
(Subramanian, Wildschutte et al. 2011, Buzdin, Lebedev et al. 2003).  It is important to note that 
all of the age estimates based on molecular clock calibrations are subject to a wide margin of 
error, as they are based on imprecise estimates of divergence dates (Johnson, Coffin 1999).  
Therefore these age estimates should only be used to provide rough estimates of absolute time, 
but are more useful for comparing relative evolution rates and ages of different HERV loci 
(Johnson, Coffin 1999).  The sequence differences of the same allele among different individuals 
can also be used as an indication of their age, but this was beyond the scope of this study. 
Functional Impact 
HERVs have played an important role in primate evolution as they are known to create 
genomic rearrangements through several recombinational processes such as the generation of 
solo-LTRs, gene conversion events, excision of sequences located between two homologous 
proviruses and the recombination between LTRs of allelic proviruses (Doxiadis, De Groot et al. 
2008).  It has also been shown that full–length provirus and solo-LTR insertions can disrupt gene 
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function or regulation of host genes to a different degree between the two types of LTR alleles 
(Doxiadis, De Groot et al. 2008).  An example is the FL LTR retrotransposon insertion located 
upstream of the VvmybA1-coding sequence in V. vinifera grapes, which alters the gene 
expression resulting in the loss of red pigmentation, resulting in a white-skinned grape 
(Kobayashi, Goto-Yamamoto et al. 2004).  In the instances where this insertion is found as a 
sLTR due to a post-insertion homologous recombination event, there is partial recovery of the 
gene expression, thus partial recovery of grape colour, resulting in two spontaneous colour 
variants of grapes (Ralli Seedless and Super Red) (Lijavetzky, Ruiz-García et al. 2006).  
Therefore it is possible for both the FL and separate homologous recombination events forming 
the sLTR alleles to have distinct impacts on the same gene.   
HERV-K and their LTRs have been found to function in vivo as enhancers, promoters, 
transcription terminators and the origin of splice sites (Dangel, Baker et al. 1995, Buzdin, 
Lebedev et al. 2003, Taruscio, Floridia et al. 2002, Doxiadis, De Groot et al. 2008, Illarionova, 
Vinogradova et al. 2007, Panaro, Calvello et al. 2009). Therefore it is important to identify the 
proximity of these insertions to their surrounding genes. To investigate if any of these 
polymorphic insertions have any functional impact within the genome, each locus was analyzed 
using the UCSC Genome Browser to determine the gene context of these insertions ( 
96 
 
Table 15).  Out of the 16 candidates examined, 12 (71%) were found to be intergenic, as 
they were located at least 2kb or further from any surrounding genes.  This result coincides with 
the supporting data that HERVs are less common in introns or in close proximity to genes than to 
intergenic regions (Kurth 2010).  These are more likely to reduce fitness and become excised or 
inactivated, leading to a disproportionate accumulation of HERV sequences in gene-sparse 
regions (Buzdin, Lebedev et al. 2003, Doxiadis, De Groot et al. 2008, Kurth 2010). As such, 
these insertions are likely to have little to no impact on the expression of any of the surrounding 
genes, but it is important to note that a lot of regulatory elements are far away from the gene, so 
these may still be able to impact the regulation of surrounding genes.  Of the remaining 
candidates, four (24%) were found within introns, and one (1%) was found ~790bp downstream 
of the nearest gene.  Although there are mixed reviews on the impact of HERV insertions found 
within introns, the impact is suspected to be most closely related to the orientation of the 
insertion and the transcription direction of the gene (Dangel, Baker et al. 1995, Buzdin, Lebedev 
et al. 2003, Taruscio, Floridia et al. 2002, Doxiadis, De Groot et al. 2008, Illarionova, 
Vinogradova et al. 2007, Panaro, Calvello et al. 2009).  Observing the insertions found within the 
introns revealed that the LTR orientation is opposite of the genes’ transcription direction in all 
four loci.  This supports the current data that HERV integrations into the introns are more likely 
found to be anti-sense to the direction of genes’ transcription, aiding to the theory that there is 
strong selection against sense-directed integrations (Illarionova, Vinogradova et al. 2007, 
Doxiadis, De Groot et al. 2008).  It has been proposed that the reason for this trend is due to the 
negative influence of sense-oriented HERVs on correct splicing of the targeted genes and post-
transcriptional gene regulation due to RNA interference (Buzdin, Lebedev et al. 2003, Doxiadis, 
De Groot et al. 2008).  This can be a consequence of the formation of double-stranded RNA 
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between mRNA and the anti-sense transcript; resulting in the degradation of all mRNAs 
containing sites homologous to the double-stranded fragment (Buzdin, Lebedev et al. 2003).  
Anti-sense orientations have been found to down-regulate splicing activity, suggesting that 
splicing/exonization by anti-sense HERVs may be suppressed due to hybridizations with sense-
oriented mRNA (Doxiadis, De Groot et al. 2008).  It has also been speculated that an anti-sense 
transcript could be generated in the case of reverse orientation of the proviral sequence during 
host transcription; which may serve as a defence against other exogenous retroviruses of 
homologous sequence (Mack, Bender et al. 2004).  This would allow protection by blocking the 
translation of newly expressed retroviral genes already in the genome, or prevent the initial 
integration of the viral DNA (Mack, Bender et al. 2004).  As such, these may provide a selective 
advantage for the host, leading to the maintenance of the insertions in these loci (Mack, Bender 
et al. 2004, Doxiadis, De Groot et al. 2008).   
Sense-oriented LTR insertions with powerful transcriptional termination signals in the 
gene intron can inactivate the gene by causing an early transcription termination (Buzdin, 
Lebedev et al. 2003).  These types of insertions are likely to be deleterious mainly in monogenic 
systems, as there is an underrepresentation of these integrations in the human genome (Doxiadis, 
De Groot et al. 2008).  Despite these observations, there have been instances where sense-
oriented HERV insertions within the introns may have had a positive effect, contributing to the 
plasticity and diversity of the primate genomes in particular with multi-gene families, with the 
majority of this activity being attributed to the splice sites within the LTR and solo-LTRs 
(Doxiadis, De Groot et al. 2008).  Therefore these studies indicate that the presence or absence of 
the insertions can have a strong influence on the particular hosts’ genes, and these genes should 
be the subject of future studies.    
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Summary and Conclusions 
Overall in this study we were able to identify a total of 17 novel polymorphic insertions 
using a broad sample of 30 individuals covering the major ethnic population groups by 
exploring three different strategies ( 
Table 11).  This represents the largest discovery of polymorphic HERVs ever found, 
increasing the known polymorphic loci by over 150%.  Of these confirmed candidates, 12 were 
classified dimorphic PI/sLTR.  One was classified dimorphic sLTR/FL, and one was dimorphic 
PI/FL.  Interestingly 2 candidates were found to exhibit a trimorphic status.  An additional 4 
candidates were found to be a fixed FL insertion.  Overall this study indicates that the level of 
HERV polymorphism is much higher than previously demonstrated in the published literature.  
All of the prediction methods used throughout this study resulted in the identification of 
polymorphic HERV loci.  While the TIPs_In prediction methods can only identify a finite 
number of polymorphic insertions, the TIPs_OUT prediction method represents a theoretically 
unlimited number of polymorphic candidate loci. The insertion age estimates of the loci tested 
place their integration time in the germline within the 1-6 million years, adding further evidence 
that HERV-K HML-2 represents the youngest HERV family in the human genome; thus HERV-
K have infected humans in recent evolutionary times.  There were four polymorphic loci that 
have inserted with the intron of surrounding genes, but as they are anti-sense orientations 
compared to the gene transcription direction, their impact can only be speculated.  Given that 
these insertions are polymorphic among the individuals tested, future studies should be directed 
at identifying the functional impact that these insertions may have on these genes.  Future studies 
should also be directed towards obtaining the sequence data associated with the novel insertions 
identified in this study that this study was unable to obtain, most notably those that are full-
length insertions.    
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 HERV insertional polymorphism identification will greatly benefit from the influx of 
personal genome data that is currently being obtained through next generation sequencing 
technologies.  As these become available, the TIPs_OUT prediction method is likely to prove the 
most suitable way to identify polymorphic insertions. Thus this method is suspected to 
demonstrate the most useful for identifying HERV insertions associated with human diseases, 
especially those that are autoimmune in nature.  As current PCR genotyping is limited by the 
“universal” internal primers needed to amplify the full-length HERV insertions, a more efficient 
method of detection is needed improve the identification of these insertions predicted using the 
TIPs_OUT algorithms.  Although the panel of 30 individuals is capable of providing information 
on the distribution of polymorphic HERV alleles, this sample size is extremely small compared 
to the current human population and a larger sample size should be used in future studies in order 
to be able to draw more accurate conclusions.   Although this study has greatly increased the 
current data on polymorphic HERVs, it is still extremely small, and the identification of new 
polymorphic loci will help provide more insight to both their current activity levels as well as 
any functional impact the may incur on the host.  Therefore future research will ultimately help 
us gain more information and insights into how our genome works and evolves. 
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Appendix 1 – TIPs_IN Positive Results 
 
A) B)  
Figure 14: PCR genotype results for the F+R primers on candidate chr4:120483136-
120484102. 
 
A) B)  
Figure 15: PCR genotype results for the F+R and F+LTR-M5R primers on candidate 
chr7:157722243-157723211. 
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A) B)  
Figure 16: PCR genotype results for the F+R and F+LTR-M5R primers on candidate 
chr8:18695738-18696706. 
 
A) B)  
Figure 17: PCR genotype results for the F+R primers on candidate chr8:37170043-
37171011. 
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Appendix 2 – FL TIPs_IN Positive Results 
 
A) B)  
Figure 18: PCR genotype results for the F+R, F+ENV_2 and R+GAG_1 primers on 
candidate chr3:185281305-185288547. 
 
A) B)  
Figure 19: PCR genotype results for the F+R, F+Int-GT16R primers on candidate 
chr3:101411706-101418889. 
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A) B)  
Figure 20: PCR genotype results for the F+R, F+GAG_1 and R+ENV_2 primers on 
candidate chr3:125610106-125617634. 
 
A) B)  
Figure 21: PCR genotype results for the combination of the F+R, F+ ENV_2 and 
R+GAG_1 primers on candidate chr10:6867110-6874635. 
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A) B)  
Figure 22: PCR genotype results for the combination of the F+R, F+ENV_2 and R+GAG_1 
primers on candidate chr12:58722211-58729730. 
 
A) B)  
Figure 23: PCR genotype results for the combination of the F+R, F+ENV_3  and 
R+GAG_1 and primers on candidate chr21:19933917-19940998.  
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Appendix 3 – TIPs_OUT Positive Results 
 
A) B)  
Figure 24: PCR genotype results for the combination of the F+R primers on candidate 
chr6:161190594-161191142. 
 
A) B)  
Figure 25: PCR genotype results for the combination of the F+R and F+3_LTR_1 primers 
on candidate chr13:89540897-89541416. 
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A) B)  
Figure 26: PCR genotype results for the combination of the F+R and F+LTR-M7R primers 
on candidate chr20:12350168-12350569. 
 
A) B)  
Figure 27: PCR genotype results for the combination of the F+R primers on candidate 
chr11:124879106-124879109. 
 
A) B)  
Figure 28: PCR genotype results for the combination of the F+R primers on candidate 
chr21:15966603-15966908. 
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A) B)  
Figure 29: PCR genotype results for the combination of the F+R primers on candidate 
chr17:4959277-4959821. 
